US.CVS · CVS Health

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.5,
      "details": {
        "atrPct": 3.310240334378265,
        "turnoverUsdM": 1186.61301,
        "liquidityPoints": 0.8,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.CVS",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 89.3642,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 2.5,
        "macd_score": 1,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 6.6,
      "take_profit_price": 102.1203,
      "target_multiplier": 1.9,
      "technical_strength": 1.6,
      "take_profit_percent": 6.7
    },
    "positionPoints": 1.5,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 6.62048066875653,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 46.5,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 39.5,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 7
  },
  "market": {
    "ma20": 105.2845,
    "ma50": 101.87,
    "close": 95.7,
    "prevClose": 96.22,
    "avgVolume20": 8631450,
    "volumeRatio": 1.44,
    "changePercent": -0.54
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 7,
    "details": {
      "ret_5d": -0.08359666762424589,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 7,
      "vcp_bonus": 0,
      "vol_ratio": 1.462302312690906,
      "ret_points": 0,
      "vol_points": 4,
      "range_ratio": 0.672975892412174,
      "volat_points": 0,
      "day_range_pct": 0.017868338557993812,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 46.5,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.7,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 54,
        "contribution": 2.7
      },
      {
        "raw": 6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 30,
        "contribution": 6
      },
      {
        "raw": 6.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 41.33,
        "contribution": 6.2
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.7,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 67,
        "contribution": 6.7
      },
      {
        "raw": 11.9,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 39.67,
        "contribution": 11.9
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "incomplete",
  "standard110": {
    "rating": "避免",
    "result": 39.5,
    "details": [
      "基本面分析總分: 2.7/5分",
      "資金流分析總分: 6/20分",
      "市場環境分析總分: 6.2/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.7/10分",
      "技術信號分析總分: 11.9/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.7,
      "資金流": 6,
      "市場環境": 6.2,
      "情緒分析": 4,
      "技術信號": 11.9,
      "風險管理": 6.7
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.4,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.4,
          "marginPoints": 0,
          "turnoverUsdM": 1186.61301,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.4,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 0.8,
          "obvPoints": 0.8,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.CVS",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 0,
            "details": {
              "source": "twelvedata+fred",
              "missing": true,
              "vixClose": null
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 700.3394962,
                "ma50": 714.56740032,
                "name": "QQQ",
                "close": 723.030029,
                "points": 1.4
              },
              "spy": {
                "ma20": 750.17250065,
                "ma50": 747.18900276,
                "name": "SPY",
                "close": 773.26001,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.310240334378265,
          "atrPoints": 2,
          "cciPoints": 0.8,
          "vixPoints": 0,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 1,
              "positiveHits": 3,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141145770,
                "url": "https://finnhub.io/api/news?id=f48593f91ec5b5050f13f5723967e5af0dfe16a3bc52d91b8dc9fefa753d8a08",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "In early August 2026, CVS Health reported second-quarter results showing higher sales of US$35,117 million and revenue of US$106.10 billion, alongside net income of US$2,979 million and materially higher earnings per share versus a year earlier. On the same day, CVS Health also raised its 2026 earnings guidance and expanded its GLP-1 weight management offering through a new collaboration with Eli Lilly, underscoring how integrated pharmacy, insurance and care-delivery assets can be combined...",
                "category": "company",
                "datetime": 1786093900,
                "headline": "CVS Health (CVS) Is Down 8.6% After Raising 2026 Guidance And Expanding GLP-1 Tie-Up With Lilly – Has The Bull Case Changed?"
              },
              {
                "id": 141142374,
                "url": "https://finnhub.io/api/news?id=bf56dd6a3f3e0b78658a6ba0a560f42183bdad7555812a1af98efdf9927a8c44",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The fair value estimate for CVS Health has shifted from US$111.92 to US$114.88, signaling a modest reset in where analysts think the stock could be worth over time. This change lines up with recent research that leans constructive on CVS Health ahead of upcoming earnings, while still calling out execution and policy risks that could affect how closely the stock trades to that mark. As you read on, you will see how to track this evolving story and what to watch as the narrative around CVS...",
                "category": "company",
                "datetime": 1786058113,
                "headline": "CVS Health (CVS) Stock Gets Fair Value Bump As Analysts Turn More Constructive"
              },
              {
                "id": 141149298,
                "url": "https://finnhub.io/api/news?id=2e654888c561e4d88d80de2bc092477efc101d8065e3b9b65dd31e4fbb0d028b",
                "image": "",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "UBS  analyst Kevin Caliendo   maintains CVS Health (NYSE:CVS) with a Buy and raises the price target from $122 to $126.",
                "category": "company",
                "datetime": 1786026475,
                "headline": "UBS Maintains Buy on CVS Health, Raises Price Target to $126"
              },
              {
                "id": 141135573,
                "url": "https://finnhub.io/api/news?id=91b721fe10a9f22d3e976c506d6e702e2ab96e3e5180de162341d7b7b8136010",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "NORTHAMPTON, MA / ACCESS Newswire / August 6, 2026 /Originally published on CVS Health Company Newsroom Key points Wildfire smoke, extreme heat and Cyclospora infections are highlighting how environmental conditions can affect health during the summer ...",
                "category": "company",
                "datetime": 1786025700,
                "headline": "Environmental Health Risks Are Rising This Summer - Here's How CVS Health Is Helping People Stay Protected"
              },
              {
                "id": 141135571,
                "url": "https://finnhub.io/api/news?id=3a019a69857e865804b7a9dee0575aa0e220f0643ccf6e20c97f6c66ed3eee19",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health lifts its 2026 outlook on Aetna's recovery and retail strength while flagging 2027 pressure from 340B changes and Caremark membership declines.",
                "category": "company",
                "datetime": 1786024800,
                "headline": "CVS Q2 Earnings Call Pairs Aetna Recovery With 2027 PBM Risks"
              },
              {
                "id": 141135574,
                "url": "https://finnhub.io/api/news?id=74783749540edf85cda36b7463044e6afb83926586dbb8833e1cea8019963dbf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Amazon’s pharmacy now offers steep discounts for weight-loss drugs, down from as much as $1,500.",
                "category": "company",
                "datetime": 1786024539,
                "headline": "Medicare Made Weight-Loss Drugs $50 A Month—Now Amazon, CVS And Walmart Race To Fill Prescriptions"
              },
              {
                "id": 141134055,
                "url": "https://finnhub.io/api/news?id=73dcce020ef97c03a7d57596eb9a4bc44edd87bd61eaaac3ae5ffea3f1ea79a9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health (NYSE:CVS) reported second-quarter results that exceeded its expectations, citing earnings growth across all operating segments and raising its full-year outlook for adjusted earnings per share and operating cash flow. Chair and Chief Executive Officer David Joyner said the company gener",
                "category": "company",
                "datetime": 1786017845,
                "headline": "CVS Health Q2 Earnings Call Highlights"
              },
              {
                "id": 141149299,
                "url": "https://finnhub.io/api/news?id=11469ef1cf267b9325cc0fffa7605bc543356ffa34df36e3107e9321c3942a6e",
                "image": "",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "Evercore ISI Group  analyst Elizabeth Anderson   maintains CVS Health (NYSE:CVS) with a Outperform and lowers the price target from $130 to $125.",
                "category": "company",
                "datetime": 1786014058,
                "headline": "Evercore ISI Group Maintains Outperform on CVS Health, Lowers Price Target to $125"
              }
            ],
            "raw_source": [
              {
                "id": 141155607,
                "url": "https://finnhub.io/api/news?id=ab6f9b1aa3a29db8aaa8e95b9cc9299577fab9ffb3cfd466d31ed70cdba189d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health (CVS) is targeting the earliest point in a customer's weight-loss drug decision: the first consultation. On Aug. 5, the company dropped the cash price of a MinuteClinic online weight-loss visit to $29, with no membership and no monthly fee. That is the lowest sticker price in the ...",
                "category": "company",
                "datetime": 1786158420,
                "headline": "Healthcare giant slashes key consultation fee to beat rivals"
              },
              {
                "id": 141152483,
                "url": "https://finnhub.io/api/news?id=5797addd1addc6df73a852eee2c2cd2d23ae1c10fa4a572980ba53e8fe9de20f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "In the health insurance arena, one company is both the undisputed leader and the most expensive ticket, forcing investors to decide if paying up for quality is a winning strategy.",
                "category": "company",
                "datetime": 1786135201,
                "headline": "UNH Leads Its Peer Group. You Pay For That"
              },
              {
                "id": 141145770,
                "url": "https://finnhub.io/api/news?id=f48593f91ec5b5050f13f5723967e5af0dfe16a3bc52d91b8dc9fefa753d8a08",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "In early August 2026, CVS Health reported second-quarter results showing higher sales of US$35,117 million and revenue of US$106.10 billion, alongside net income of US$2,979 million and materially higher earnings per share versus a year earlier. On the same day, CVS Health also raised its 2026 earnings guidance and expanded its GLP-1 weight management offering through a new collaboration with Eli Lilly, underscoring how integrated pharmacy, insurance and care-delivery assets can be combined...",
                "category": "company",
                "datetime": 1786093900,
                "headline": "CVS Health (CVS) Is Down 8.6% After Raising 2026 Guidance And Expanding GLP-1 Tie-Up With Lilly – Has The Bull Case Changed?"
              },
              {
                "id": 141147433,
                "url": "https://finnhub.io/api/news?id=882adc34ba07a7a2f13fc55561a82ca8c944fad64029aae0fbbe759d7a571960",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/07/Kumamoto--Japan---Nov-24-2020--Close-Up-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "Amazon Pharmacy offers eligible Medicare patients weight-loss drugs for $50 monthly under a new federal program.",
                "category": "company",
                "datetime": 1786087122,
                "headline": "Ozempic For $50 a Month? Amazon Pharmacy Rolls Out Cheap Weight-Loss Drugs for Medicare Patients"
              },
              {
                "id": 141142374,
                "url": "https://finnhub.io/api/news?id=bf56dd6a3f3e0b78658a6ba0a560f42183bdad7555812a1af98efdf9927a8c44",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The fair value estimate for CVS Health has shifted from US$111.92 to US$114.88, signaling a modest reset in where analysts think the stock could be worth over time. This change lines up with recent research that leans constructive on CVS Health ahead of upcoming earnings, while still calling out execution and policy risks that could affect how closely the stock trades to that mark. As you read on, you will see how to track this evolving story and what to watch as the narrative around CVS...",
                "category": "company",
                "datetime": 1786058113,
                "headline": "CVS Health (CVS) Stock Gets Fair Value Bump As Analysts Turn More Constructive"
              },
              {
                "id": 141135572,
                "url": "https://finnhub.io/api/news?id=2dcf4ca4082580e017b0b179a2654bdfbb66a0417e7f014bbd00506f20b656f8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Oscar Health’s medical loss ratio—the percentage of premium revenue spent on medical claims—fell to 79.2% from 91.1%,",
                "category": "company",
                "datetime": 1786028820,
                "headline": "Oscar Health Stock Falls After Earnings Beat and Guidance Hike"
              },
              {
                "id": 141149298,
                "url": "https://finnhub.io/api/news?id=2e654888c561e4d88d80de2bc092477efc101d8065e3b9b65dd31e4fbb0d028b",
                "image": "",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "UBS  analyst Kevin Caliendo   maintains CVS Health (NYSE:CVS) with a Buy and raises the price target from $122 to $126.",
                "category": "company",
                "datetime": 1786026475,
                "headline": "UBS Maintains Buy on CVS Health, Raises Price Target to $126"
              },
              {
                "id": 141135573,
                "url": "https://finnhub.io/api/news?id=91b721fe10a9f22d3e976c506d6e702e2ab96e3e5180de162341d7b7b8136010",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "NORTHAMPTON, MA / ACCESS Newswire / August 6, 2026 /Originally published on CVS Health Company Newsroom Key points Wildfire smoke, extreme heat and Cyclospora infections are highlighting how environmental conditions can affect health during the summer ...",
                "category": "company",
                "datetime": 1786025700,
                "headline": "Environmental Health Risks Are Rising This Summer - Here's How CVS Health Is Helping People Stay Protected"
              },
              {
                "id": 141135571,
                "url": "https://finnhub.io/api/news?id=3a019a69857e865804b7a9dee0575aa0e220f0643ccf6e20c97f6c66ed3eee19",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health lifts its 2026 outlook on Aetna's recovery and retail strength while flagging 2027 pressure from 340B changes and Caremark membership declines.",
                "category": "company",
                "datetime": 1786024800,
                "headline": "CVS Q2 Earnings Call Pairs Aetna Recovery With 2027 PBM Risks"
              },
              {
                "id": 141135574,
                "url": "https://finnhub.io/api/news?id=74783749540edf85cda36b7463044e6afb83926586dbb8833e1cea8019963dbf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Amazon’s pharmacy now offers steep discounts for weight-loss drugs, down from as much as $1,500.",
                "category": "company",
                "datetime": 1786024539,
                "headline": "Medicare Made Weight-Loss Drugs $50 A Month—Now Amazon, CVS And Walmart Race To Fill Prescriptions"
              },
              {
                "id": 141134168,
                "url": "https://finnhub.io/api/news?id=43b6a86813caef07467b33bc73f0cc2783705a8dc341743143ddb802b51d6bfe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "NEW YORK, August 06, 2026--Leap, the healthcare company making specialty medicine more affordable and easier to access, today announced the appointment of Christine Hummel as Senior Vice President of Manufacturer and Specialty Network Partnerships. In this role, she will lead Leap's strategy and partnerships across pharmaceutical manufacturers and specialty care networks, helping expand access to specialty therapies through more transparent and efficient models of care.",
                "category": "company",
                "datetime": 1786021200,
                "headline": "Leap Expands Manufacturer & Specialty Network Partnerships with Appointment of Industry Executive Christine Hummel"
              },
              {
                "id": 141134055,
                "url": "https://finnhub.io/api/news?id=73dcce020ef97c03a7d57596eb9a4bc44edd87bd61eaaac3ae5ffea3f1ea79a9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health (NYSE:CVS) reported second-quarter results that exceeded its expectations, citing earnings growth across all operating segments and raising its full-year outlook for adjusted earnings per share and operating cash flow. Chair and Chief Executive Officer David Joyner said the company gener",
                "category": "company",
                "datetime": 1786017845,
                "headline": "CVS Health Q2 Earnings Call Highlights"
              },
              {
                "id": 141133309,
                "url": "https://finnhub.io/api/news?id=81dddb0c38203b3de1a535c4e7a47071eabf2758c9b8dfe9391f5b4c9e44c16f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Oscar Health’s medical loss ratio—the percentage of premium revenues spent on medical claims—fell to 79.2% from 91.1%,",
                "category": "company",
                "datetime": 1786014300,
                "headline": "Oscar Health Stock Jumps as Earnings Crush Estimates and Insurer Hikes Guidance"
              },
              {
                "id": 141149299,
                "url": "https://finnhub.io/api/news?id=11469ef1cf267b9325cc0fffa7605bc543356ffa34df36e3107e9321c3942a6e",
                "image": "",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "Evercore ISI Group  analyst Elizabeth Anderson   maintains CVS Health (NYSE:CVS) with a Outperform and lowers the price target from $130 to $125.",
                "category": "company",
                "datetime": 1786014058,
                "headline": "Evercore ISI Group Maintains Outperform on CVS Health, Lowers Price Target to $125"
              },
              {
                "id": 141134544,
                "url": "https://finnhub.io/api/news?id=d0d64bbdcd79606726e03119bdfdb0a731a30282a3d8f220f8cae19e2ac6c4fc",
                "image": "",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "Barclays  analyst Andrew Mok   maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $106 to $108.",
                "category": "company",
                "datetime": 1786007993,
                "headline": "Barclays Maintains Overweight on CVS Health, Raises Price Target to $108"
              },
              {
                "id": 141130047,
                "url": "https://finnhub.io/api/news?id=9b27a3c7657b224a497f3e1ff2e43602e193206a8c5955bf39ba3cf8eb4cc35c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "As investors look to balance growth opportunities with defensive positioning, Acadia Pharmaceuticals, CVS Health, and Eli Lilly stand out as healthcare names combining resilient business models with strong earnings momentum.",
                "category": "company",
                "datetime": 1785971400,
                "headline": "3 Medical Stocks Standing Out After Crushing Q2 Earnings Expectations"
              },
              {
                "id": 141127522,
                "url": "https://finnhub.io/api/news?id=9d3526d3d34e4e471b97e7fca313369343da5585baacd253014ffc46e6ad5890",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Investors pay particular attention to a health insurer’s second-quarter report, which reflects more medical claims data among members.",
                "category": "company",
                "datetime": 1785964200,
                "headline": "Oscar Health Stock Has Doubled This Year. The ACA Insurer Reports Thursday."
              },
              {
                "id": 141127417,
                "url": "https://finnhub.io/api/news?id=8a291b4825c161edc5c13ce4039297c926b2d077597950a58d1d1376ec858fdd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health  stock fell Wednesday, even after the healthcare giant raised its full-year guidance on the back of second-quarter earnings that handily beat analysts’ projections.  While analysts reacted positively to the earnings announcement, company executives spoke in more detail on an investor call about sources of pressure during the quarter—including from a federal drug pricing program called 340B.  The “incremental angst” on the 2027 outlook is “the clear pressure point for the stock,” said Leerink Partners analyst Michael Cherny in a client note Wednesday afternoon.",
                "category": "company",
                "datetime": 1785962460,
                "headline": "CVS Health Raised Its Outlook, but the Stock Still Fell"
              },
              {
                "id": 141130878,
                "url": "https://finnhub.io/api/news?id=0402786319e4fdd3ec7d886f1d5b3be8d32a3ec8d5d4f55e259a02de52dc9a78",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Eli Lilly shares rally on a fresh DTC partnership with CVS Health. A strong Q2 release and impressive future guidance is driving LLY stock higher as well.",
                "category": "company",
                "datetime": 1785959430,
                "headline": "LLY Stock Alert: What to Know as Eli Lilly Teams Up With CVS on Weight-Loss Drugs"
              },
              {
                "id": 141125974,
                "url": "https://finnhub.io/api/news?id=c459a2f7de46fc6a834ac3b2bb9cc7e13ce53f1f2b0e244f6bdd50b5191a689c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index and the State",
                "category": "company",
                "datetime": 1785959404,
                "headline": "Sector Update: Healthcare Stocks Rise Late Afternoon"
              },
              {
                "id": 141125823,
                "url": "https://finnhub.io/api/news?id=52c9038a748a6b293558d7a5000c967cbbe13bc9f3c9facdf507a7a1387bb8c6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health Corp (CVS) delivered a 40% surge in adjusted EPS, raised its full-year outlook, and outlined a clear path to offset 2027 headwinds with strategic growth initiatives.",
                "category": "company",
                "datetime": 1785956641,
                "headline": "CVS Health Corp (CVS) (Q2 2026) Earnings Call Highlights: Strong Earnings Beat and Raised ..."
              },
              {
                "id": 141125659,
                "url": "https://finnhub.io/api/news?id=21fb8be31f4b117b356767c095e95409cad32b2d646651192a1c1ccf094f1c80",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "SpaceX stock sinks after earnings. AMD drops after Elon Musk says his AI and space company will exclusively use Nvidia chips.",
                "category": "company",
                "datetime": 1785955380,
                "headline": "SpaceX, Alphabet, Nvidia, Micron, AMD, Uber, CVS, Lilly, and More Stocks That Explain Today’s Market"
              },
              {
                "id": 141125825,
                "url": "https://finnhub.io/api/news?id=cbaabac877d58e1e2a913ef2949e8aedc3dca6dce4624c2f4917842af3c93721",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "A major 2026 guidance increase could not satisfy investors expecting a faster earnings recovery next year.",
                "category": "company",
                "datetime": 1785955005,
                "headline": "CVS Stock Drops 5.8% as 2027 Outlook Disappoints"
              },
              {
                "id": 141124159,
                "url": "https://finnhub.io/api/news?id=4395029b748f9c1773424c0bf90efdad8a55a4105535e31630585af3b828c074",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health (CVS) is collaborating with Eli Lilly (LLY) as part of enhancements to its direct-to-cons",
                "category": "company",
                "datetime": 1785951879,
                "headline": "CVS, Eli Lilly Forge Partnership on Improved GLP-1 Access; Companies Top Second-Quarter Views"
              },
              {
                "id": 141124161,
                "url": "https://finnhub.io/api/news?id=59cac24a44287e15270a423ae9fcdc1b7050b90eecf09e7918eddc9a1509305c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Healthcare stocks were higher Wednesday afternoon, with the NYSE Healthcare Index rising 1.1% and th",
                "category": "company",
                "datetime": 1785951758,
                "headline": "Sector Update: Healthcare Stocks Advance Wednesday Afternoon"
              },
              {
                "id": 141122814,
                "url": "https://finnhub.io/api/news?id=f20e7a2dc06254658a41134e30d368a56ecc0f48db7eba719532e87e7cbbd867",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health  stock was falling Wednesday morning after the healthcare giant raised its full-year guidance on the back of second-quarter earnings that handily beat analysts’ projections.  The 6% decline in share price reversed a 3.9% rise during premarket trading.  While analysts reacted positively to the earnings announcement, company executives spoke in more detail on an investor call about sources of pressure during the quarter—including from a federal drug pricing program called 340B.",
                "category": "company",
                "datetime": 1785950580,
                "headline": "CVS Health Raises Earnings Outlook, but the Stock Is Falling"
              },
              {
                "id": 141123471,
                "url": "https://finnhub.io/api/news?id=d76e7dff95c6b1f2ab3eec4aeef8f0996262f2a3cd080007be3ff36d529d15d1",
                "image": "https://www.chartmill.com/images/uploads/CM_Unusual_Volume_Small_free_b9d2e60841.webp",
                "source": "ChartMill",
                "related": "CVS",
                "summary": "Let's have a look at the S&P500 stocks with an unusual volume in today's session.",
                "category": "company",
                "datetime": 1785949500,
                "headline": "These S&P500 stocks have an unusual volume in today's session"
              },
              {
                "id": 141124325,
                "url": "https://finnhub.io/api/news?id=7f69787e0b1dad8b84f3fcd5b89d6e777fe0604b5b749a79f2de0dadb297a9a4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Moby summary of CVS Health Corporation's Q2 2026 earnings call",
                "category": "company",
                "datetime": 1785948349,
                "headline": "CVS Health Corporation Q2 2026 Earnings Call Summary"
              },
              {
                "id": 141123271,
                "url": "https://finnhub.io/api/news?id=41596b07c037fe81a6963035041969d9a5305c9b2c7c1ef2d76aaea6efc80395",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "CVS",
                "summary": "Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.",
                "category": "company",
                "datetime": 1785947701,
                "headline": "Top S&P500 movers in Wednesday's session"
              },
              {
                "id": 141126014,
                "url": "https://finnhub.io/api/news?id=4ca154ba64515bee5ba02348b2bcfc96c4b3f716d2aaef53bf1dd2abbbbb6145",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2217256698/image_2217256698.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CVS",
                "summary": "Teva Pharmaceutical Industries Limited turnaround: Pivot to Growth, raised 2026 guidance, $3.7B specialty target, and more. Click for this TEVA update.",
                "category": "company",
                "datetime": 1785945929,
                "headline": "Teva Pharmaceuticals: Continuing To Execute On Its 'Pivot To Growth' Plan"
              },
              {
                "id": 141122822,
                "url": "https://finnhub.io/api/news?id=66feb67d01e4d70e0094ed3a397369ee81fb7e771b1a676824a3bc9007bf3596",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "SpaceX stock sinks after earnings. AMD drops after Elon Musk says his AI and space company will exclusively use Nvidia chips.",
                "category": "company",
                "datetime": 1785945720,
                "headline": "SpaceX, Nvidia, Micron, AMD, Uber, CVS, Lilly, and More Stocks That Explain Today’s Market"
              },
              {
                "id": 141124168,
                "url": "https://finnhub.io/api/news?id=fe18b167af707b0fc63be22f01d9e144cb609bf75d08bf2943724d668be19325",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "US equities were mixed and crude oil eased in late-morning trading Wednesday as investors remained h",
                "category": "company",
                "datetime": 1785945478,
                "headline": "Top Midday Stories: SpaceX Shares Fall After Inaugural Results; AMD Drops Despite Strong Q2 EPS, Revenue"
              },
              {
                "id": 141124226,
                "url": "https://finnhub.io/api/news?id=5b6f0956188068f745ee45976b72540b207bf00c682395f6f0b21b550c1e5902",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "UnitedHealth's revenue held up; the operating margin on it did not, and closing that gap is the whole upside case.",
                "category": "company",
                "datetime": 1785945015,
                "headline": "The Case For UnitedHealth Stock Is Margin, Not Growth"
              },
              {
                "id": 141124170,
                "url": "https://finnhub.io/api/news?id=03a2bc0898c99d3044ff5ff8aa38241e509893ae0cce5938dafa73efca4374d2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "July Private Payrolls Well Below Expectations .",
                "category": "company",
                "datetime": 1785942360,
                "headline": "July Private Payrolls Well Below Expectations"
              },
              {
                "id": 141122626,
                "url": "https://finnhub.io/api/news?id=58a15b44e6d2f30ec912b83409f3e2d1c0ef508c700c44a604ad2b5acd9feb25",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "After the company reported second quarter earnings and raised its full-year sales guidance, Eli Lilly (LLY) CFO Lucas Montarce outlines the expansion opportunities that the pharmaceutical giant is seeing in its GLP-1 category, specifically the introduction of oral weight-loss drugs to the market.",
                "category": "company",
                "datetime": 1785942143,
                "headline": "Eli Lilly is treating nearly 10% of US obesity population with GLP-1s: CFO"
              },
              {
                "id": 141122627,
                "url": "https://finnhub.io/api/news?id=ac0910e0310266d58ddd74b4a207e86e20caee01b34caa377cfe4e66399f2546",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health Corp (NYSE:CVS) reported second-quarter revenue and profit that beat Wall Street estimates on Wednesday, and raised its full-year adjusted earnings guidance, though cautious guidance pressured shares. Revenue rose 7.3% year-over-year to $106.1 billion, above analyst estimates of...",
                "category": "company",
                "datetime": 1785941580,
                "headline": "CVS Health tops second-quarter estimates, raises full-year profit outlook"
              },
              {
                "id": 141122424,
                "url": "https://finnhub.io/api/news?id=1ca035af56beda0d6c99392b7b7fec70c023883da92857f33ebd9fda702f3039",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health earnings surged past tepid forecasts as health benefit costs fell as a share of premiums.  CVS stock initially jumped but reversed sharply lower.  Management's 2027 outlook shared on the earnings call may have been the trigger.",
                "category": "company",
                "datetime": 1785940649,
                "headline": "CVS Stock Slides On 2027 Outlook Despite Hearty Earnings Beat"
              },
              {
                "id": 141121867,
                "url": "https://finnhub.io/api/news?id=6beb908ae12813dfd98a52eb52bb2db4a5234cb5fae50594bf2bc304a6172d38",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "CVS",
                "summary": "Wondering which stocks are making significant price gaps? Explore the S&P500 index on Wednesday to find the gap up and gap down stocks in today's session.",
                "category": "company",
                "datetime": 1785940501,
                "headline": "Which S&P500 stocks are gapping on Wednesday?"
              },
              {
                "id": 141122365,
                "url": "https://finnhub.io/api/news?id=f6f3af235fa649b2b6406ff363a525cc8f9e5d4580756ff2f674571db4e9f064",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Today's ADP private-sector payrolls came in below the +75K forecast and less than half the downwardly revised +95K from June.",
                "category": "company",
                "datetime": 1785940380,
                "headline": "ADP Cools to +44K, Earnings Show Beats from DIS, LLY & More"
              },
              {
                "id": 141122630,
                "url": "https://finnhub.io/api/news?id=f0d3f50c1dc72e766cb1b44a80ca4169797e7933306849ac32ca38bbb7329306",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS beats Q2 earnings and revenue estimates as stronger segment performance lifts results and prompts raised 2026 guidance, sending shares higher.",
                "category": "company",
                "datetime": 1785939600,
                "headline": "CVS Health Q2 Earnings and Revenues Top Estimates, Stock Climbs"
              },
              {
                "id": 141124772,
                "url": "https://finnhub.io/api/news?id=1db0cc6302bebe93b61e5eb9d2a4357679405616901a47c4a140ddf7ad352f6e",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/05/Digital-Gold-Price-Stock-Market-Trading-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "Gold posts its biggest one-day gain since February and the Dow sets a record as Iran deal hopes cool inflation fears.",
                "category": "company",
                "datetime": 1785939260,
                "headline": "Gold Jumps 4%, Dow Jones Smashes Record Highs: Stock Market Today"
              },
              {
                "id": 141121322,
                "url": "https://finnhub.io/api/news?id=9770cbb138df3ea23f26123bd7da600ffe9b7bcd832f9c11100096e5747ab5e7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health earnings surged past tepid forecasts as health benefit costs fell as a share of premiums.  CVS stock initially jumped but reversed sharply lower.  Analysts say that management's prudence in trying to grow its health benefits business let the company avoid the worst fallout from surprisingly strong medical care utilization.",
                "category": "company",
                "datetime": 1785937826,
                "headline": "CVS Stock Slides Despite Hearty Q2 Earnings Beat"
              },
              {
                "id": 141122425,
                "url": "https://finnhub.io/api/news?id=12db69f9cdafe0ff2686b26b189d80dad081635d4359a46491954e6398f22fb1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "(Bloomberg) -- CVS Health Corp. shares fell after the company gave preliminary 2027 profit guidance that disappointed investors and warned of challenges in its pharmacy benefit manager next year, overshadowing a better-than-expected second quarter report.Most Read from BloombergTrump Says Iran Talks Going Well as Hopes Rise for Hormuz DealSpaceX’s AI Splurge Puts Damper on Debut Earnings After IPOChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersTaco Bell Met With Michigan on Parasi",
                "category": "company",
                "datetime": 1785937308,
                "headline": "CVS Falls After Preliminary 2027 Guidance Disappoints"
              },
              {
                "id": 141122632,
                "url": "https://finnhub.io/api/news?id=b7ada71d10b7e0b6ea4cc24a468f1975066e364717be6dc38855863c05e771c5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Although the revenue and EPS for CVS Health (CVS) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
                "category": "company",
                "datetime": 1785936611,
                "headline": "CVS Health (CVS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates"
              },
              {
                "id": 141121177,
                "url": "https://finnhub.io/api/news?id=23e6ddf098968bb77ad4c266e778419394fc5af585454c4207229c455f8f2bdd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The benchmark US stock measures were trending higher in Wednesday's premarket activity amid growing",
                "category": "company",
                "datetime": 1785932158,
                "headline": "Stocks Rise Pre-Bell Amid Growing Hopes for Hormuz Deal; Traders Await More Corporate Earnings"
              },
              {
                "id": 141126657,
                "url": "https://finnhub.io/api/news?id=102821957d81bb6ecefd074516db590840004b773fb1251f461daf4fc9b1a344",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/05/Eli-Lilly.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "Eli Lilly (LLY) beat Q2 earnings expectations & raised 2026 guidance as Mounjaro and Zepbound drove $22.97B in revenue. Read more.",
                "category": "company",
                "datetime": 1785931562,
                "headline": "Eli Lilly's Weight-Loss Empire Keeps Expanding As Mounjaro, Zepbound Generate Nearly $15 Billion"
              },
              {
                "id": 141122866,
                "url": "https://finnhub.io/api/news?id=17236f965ec01998ce752a09d51f74d2ddc9007795881d31abc231d4ff1d739f",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "CVS",
                "summary": "CVS Health Corporation (CVS) Q2 2026 Earnings Call August 5, 2026 8:00 AM EDTCompany ParticipantsLarry McGrath - Executive Vice President of Capital MarketsJ.",
                "category": "company",
                "datetime": 1785931203,
                "headline": "CVS Health Corporation (CVS) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141121324,
                "url": "https://finnhub.io/api/news?id=872a22e9780de7af73f717593f1045b3e9d6c8c854db2c36ad7c45214242bbd9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health (NYSE:CVS) shares climbed around 5% in pre-market trading on Wednesday after the healthcare company reported second-quarter earnings that comfortably exceeded Wall Street expectations and increased its full-year profit forecast. The company posted earnings of $2.",
                "category": "company",
                "datetime": 1785930827,
                "headline": "CVS Health raises 2026 outlook after stronger-than-expected second-quarter results"
              },
              {
                "id": 141121182,
                "url": "https://finnhub.io/api/news?id=7c4ce0f908d266e0a4970e774a4b67966e9d4e4b1d62bc117b581f4d3460416d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health  stock jumped on Wednesday after the healthcare giant raised its full-year guidance on the back of second-quarter earnings that handily beat analysts’ projections.  For the second quarter, CVS Health posted adjusted earnings of $2.58 a share.  Analysts polled by FactSet were looking for $1.85 a share.",
                "category": "company",
                "datetime": 1785930360,
                "headline": "CVS Health Stock Climbs on Earnings Outlook Hike and Lilly Weight-Loss Drug Partnership"
              },
              {
                "id": 141121326,
                "url": "https://finnhub.io/api/news?id=cbf9a1407c933e2d5b65007acd102a76795412d5fbdb041da0e43e30c5221014",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health (CVS) delivered earnings and revenue surprises of +37.97% and +5.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785930303,
                "headline": "CVS Health (CVS) Q2 Earnings and Revenues Beat Estimates"
              },
              {
                "id": 141126659,
                "url": "https://finnhub.io/api/news?id=7e824d5fc0498be0330b6a1b6a4f72e935b57b1fd79519120c19db556ab88f7e",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/05/Chandler--Arizona---April-08-2023cvs-Hea.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "CVS Health beats Q2 earnings expectations and hikes FY26 guidance, but shares fall on profit-taking. Get the full financial breakdown.",
                "category": "company",
                "datetime": 1785928740,
                "headline": "CVS Targets Affordable GLP-1 Access With New Eli Lilly Deal"
              },
              {
                "id": 141120281,
                "url": "https://finnhub.io/api/news?id=58dfabf5f7af002f0732ad56dad186c29b6f822a3e53e90defbc09c7a4af8ee2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS beat Wall Street expectations by a wide margin in the second quarter and raised its full-year profit forecast to as much as $8.10 per share",
                "category": "company",
                "datetime": 1785928512,
                "headline": "CVS Health Q2 2026 earnings beat, Eli Lilly weight loss drug deal"
              },
              {
                "id": 141120285,
                "url": "https://finnhub.io/api/news?id=576355aedb6054103db654b08daf20745d83dd6aa5b71729852a8db41f208396",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Investing.com -- CVS Health shares jumped about 5% in premarket trading Wednesday after the company raised its full-year profit guidance following better-than-expected second-quarter results.",
                "category": "company",
                "datetime": 1785928308,
                "headline": "CVS shares jump on earnings beat, raised full-year guidance"
              },
              {
                "id": 141120395,
                "url": "https://finnhub.io/api/news?id=781c37246e8761b14cc57d0967c05477668e0b8a5049f31745d9e36a2ebe6516",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Diversified healthcare company CVS Health (NYSE:CVS) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 7.3% year on year to $106.1 billion. Its non-GAAP profit of $2.58 per share was 39.4% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1785926638,
                "headline": "CVS Health (NYSE:CVS) Reports Bullish Q2 CY2026"
              },
              {
                "id": 141120396,
                "url": "https://finnhub.io/api/news?id=14c0074d8b7b6801858df1a5b5ad9e2dcb7519b852793c428588c6d4e9ba1a98",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended June 30, 2026.",
                "category": "company",
                "datetime": 1785925800,
                "headline": "CVS HEALTH CORPORATION REPORTS STRONG SECOND QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE"
              },
              {
                "id": 141120286,
                "url": "https://finnhub.io/api/news?id=929390d508df1918042148d3135c588fa170cbc68ae07a72befdd063e0556902",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health® (NYSE: CVS) today announced a revamp of its weight management program, making it easier for eligible adults to access clinical care, navigate medication costs and get ongoing support for GLP-1 therapy.",
                "category": "company",
                "datetime": 1785925500,
                "headline": "CVS Health enhances its direct-to-consumer weight management offerings to improve access, affordability, care and support for GLP-1 medications"
              },
              {
                "id": 141121003,
                "url": "https://finnhub.io/api/news?id=9e3671601ad93f5df09c39b69ee23b786c22f24674bb047ee12815ebe9c366b5",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "CVS",
                "summary": "2026-08-05. The following slide deck was published by CVS Health Corporation in conjunction with their 2026 Q2 earnings call.",
                "category": "company",
                "datetime": 1785922598,
                "headline": "CVS Health Corporation 2026 Q2 - Results - Earnings Call Presentation"
              },
              {
                "id": 141127704,
                "url": "https://finnhub.io/api/news?id=f78bb8b6194010656fda1fc47f6f2c8f8deeb2315029ba9ce7f5053ba265658b",
                "image": "",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "-Conference Call ",
                "category": "company",
                "datetime": 1785918500,
                "headline": "CVS Health Exec Says Co. Will See Membership Declines In Care Mark Next Year"
              },
              {
                "id": 141123551,
                "url": "https://finnhub.io/api/news?id=86a8c46f2404b017c84a3d0e83c9f5f12e60c3619e2b79a753be6a89abf1e623",
                "image": "https://image.cnbcfm.com/api/v1/image/108260244-1770052587895-gettyimages-2259048430-US_STOCKS.jpeg?v=1776173571&w=1920&h=1080",
                "source": "CNBC",
                "related": "CVS",
                "summary": "These are the stocks posting the largest moves premarket.",
                "category": "company",
                "datetime": 1785915090,
                "headline": "Stocks making the biggest moves premarket: SpaceX, AMD, Eli Lilly, Disney & more"
              },
              {
                "id": 141123617,
                "url": "https://finnhub.io/api/news?id=40fb621f7b14e76053c9573d62bacb46c9991297142f0e178eef278adbff0d4b",
                "image": "https://image.cnbcfm.com/api/v1/image/108345132-17859268651785926824-47590185922-1080pnbcnews.jpg?v=1785926864&w=1920&h=1080",
                "source": "CNBC",
                "related": "CVS",
                "summary": "CNBC's Becky Quick reports on the company's quarterly earnings results.",
                "category": "company",
                "datetime": 1785912823,
                "headline": "CVS blows past estimates, hikes guidance as insurance unit continues to improve"
              },
              {
                "id": 141127705,
                "url": "https://finnhub.io/api/news?id=3bdc546184ff036816555bd91cc2003b41f116a243ea34d5542bf774434587cd",
                "image": "",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "CVS Health (NYSE:CVS) raises FY2026 GAAP EPS guidance from $6.24-$6.44 to $6.84-$7.04 vs $6.12 analyst estimate..",
                "category": "company",
                "datetime": 1785911581,
                "headline": "CVS Health Raises FY2026 GAAP EPS Guidance from $6.24-$6.44 to $6.84-$7.04 vs $6.12 Est"
              },
              {
                "id": 141127706,
                "url": "https://finnhub.io/api/news?id=ff0a81fa84cb8046ef00f0b8d6d980b4adfda82e406f25adb65686e7224f5433",
                "image": "",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "=",
                "category": "company",
                "datetime": 1785911477,
                "headline": "CVS Health Q2 Adj. EPS $2.58 Beats $1.85 Estimate, Sales $106.096B Beat $100.114B Estimate"
              },
              {
                "id": 141125527,
                "url": "https://finnhub.io/api/news?id=c78b593c886378d2e8dbd934f656f7b237dca8776a47b308ee652114a9f38654",
                "image": "",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "CVS Pharmacy offers all FDA approved GLP-1s, whether through insurance or cash-pay options.New collaboration with Eli Lilly and Company will provide eligible Zepbound and Foundayo patients an additional access point at",
                "category": "company",
                "datetime": 1785911349,
                "headline": "CVS Health Retools Its Weight Management Program To Make It Easier For Eligible Adults To Access Clinical Care, Navigate Medication Costs And Get Ongoing Support For GLP-1 Therapy"
              },
              {
                "id": 141116522,
                "url": "https://finnhub.io/api/news?id=60a1c66ca6e08dbb795bcca07894c52b9b2505094d2bee211affc25ecb15b545",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health reports earnings Wednesday, with analysts expecting another solid quarter and looking for potential guidance upside from its Aetna insurance and Caremark pharmacy-benefit businesses.",
                "category": "company",
                "datetime": 1785882660,
                "headline": "CVS’s Turnaround Faces Its Next Test"
              },
              {
                "id": 141110138,
                "url": "https://finnhub.io/api/news?id=c6c1c009b8e4bec33f6cf816603922f75e6049dda7d111258e3afcbe858e8d04",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "NORTHAMPTON, MA / ACCESS Newswire / August 4, 2026 /Originally published on CVS Health Company Newsroom As health care continues to evolve, employers are increasingly looking beyond recruitment to ensure they have the talent needed for the future. ...",
                "category": "company",
                "datetime": 1785853800,
                "headline": "CVS Health Uses Career Development Programs To Build Its Future Workforce"
              },
              {
                "id": 141109884,
                "url": "https://finnhub.io/api/news?id=2ed550b3c1ba3a7c82430579ec821554131c464b05b1cd86c7d367511c249b6b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Hims and Hers has 2.6 million subscribers, a battered stock price, and a CEO buying shares instead of signaling an exit. That combination puts a very specific list of giants on alert, and only one of them is a clean fit.",
                "category": "company",
                "datetime": 1785852929,
                "headline": "Why Hims & Hers Is the Perfect Acquisition Target (Even If a Deal Never Happens)"
              },
              {
                "id": 141108739,
                "url": "https://finnhub.io/api/news?id=53a3e2695df1be17869719dabc2f021964ef3fd8268a70d8d3b90ed8df4e250c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health® (NYSE: CVS) today announced that its AI Learning Academy earned two Golds and one Silver at the 11th Annual Stevie Awards for Great Employers, a global honor recognizing organizations for excellence in employee development, training and workplace culture. The company earned Gold in the Employee Upskill/Reskill Training and AI Workforce Innovation Team of the Year categories, and Silver in AI in Learning and Skills Development Achievement.",
                "category": "company",
                "datetime": 1785848400,
                "headline": "CVS Health earns two Gold and one Silver Stevie® Awards for Great Employers"
              },
              {
                "id": 141102940,
                "url": "https://finnhub.io/api/news?id=4994f47996da2987119a207d9803c9d7f3e2e6f926e9e2c819982339354579ac",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The company published the arithmetic of its own margin repair, and the first hard proof landed a quarter before the shares started compounding.",
                "category": "company",
                "datetime": 1785788221,
                "headline": "CVS Health Stock Surged On An Aetna Recovery That Management Had Already Sized"
              },
              {
                "id": 141100970,
                "url": "https://finnhub.io/api/news?id=95d822ee91c0a0cc48471f8acebb5fb05b231e3976ca2b093bd2b00c701fc22d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
                "category": "company",
                "datetime": 1785773402,
                "headline": "Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?"
              },
              {
                "id": 141100799,
                "url": "https://finnhub.io/api/news?id=d46fd0559574ac4eac770af70d63416cb7bf5ca3c714c66214f86cd46bbc16ea",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS heads into Q2 earnings with estimates pointing to revenue and EPS growth as Aetna initiatives and key business segments support results.",
                "category": "company",
                "datetime": 1785765300,
                "headline": "CVS Health's Q2 Earnings on Deck: How Should You Play the Stock?"
              },
              {
                "id": 141098792,
                "url": "https://finnhub.io/api/news?id=c8eda5ddd3d63cef9398048bd6a71863c6762b186799de923cde8c939c0aa231",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "As employers drop coverage for GLP-1 drugs like Wegovy and Zepbound, retail giants are competing to lock in customers through direct-to-consumer programs",
                "category": "company",
                "datetime": 1785763887,
                "headline": "Walmart, Costco, Amazon racing to capture weight loss drug customers"
              },
              {
                "id": 141094788,
                "url": "https://finnhub.io/api/news?id=3f8727d0954fad695567eb16f68ec5e7fe7d41f5b4a4c5ebe2490ea343301f49",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "In another heavy earnings week, we’ll also see reports from McDonald’s, Disney, Uber, Devon Energy, and more.",
                "category": "company",
                "datetime": 1785693600,
                "headline": "Jobs Report, Palantir, AMD, SpaceX, Eli Lilly, and More to Watch This Week"
              },
              {
                "id": 141082659,
                "url": "https://finnhub.io/api/news?id=ae19f98877c95cfdfeea2f8cb535684db68c4c71acb25174a7b7f6b9d3c88b6a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Recent earnings expectations and fresh store openings have put CVS Health (CVS) in focus for investors. The stock now sits near US$105 after a strong past year, raising questions about what is already reflected in the price. See our latest analysis for CVS Health. Over the past year, CVS Health has seen its share price move sharply higher, supported by a 90 day share price return of 28.18% and a 1 year total shareholder return of 74.81%. Recent store openings, product launches and...",
                "category": "company",
                "datetime": 1785532157,
                "headline": "CVS Health (CVS) Draws Earnings Buzz, Is 6% Undervalued Enough?"
              },
              {
                "id": 141081603,
                "url": "https://finnhub.io/api/news?id=774670f2ffd3beaa99c496440a96672a27464f499e7060b191aec589c3813ef2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health stock has returned 74.8% over the past year, yet its broader valuation checks lean expensive, so investors are weighing a strong share price run against signals that the stock may already be pricing in a lot of good news. Over the last 12 months, CVS Health has delivered a 74.8% return, which puts recent holders in a strong position and naturally raises the bar for what future returns need to justify today’s price. Expectations around CVS Health’s ability to grow healthcare and...",
                "category": "company",
                "datetime": 1785521354,
                "headline": "CVS (CVS) Stock Looks Overvalued As 340B Pricing Lawsuit Looms"
              },
              {
                "id": 141081604,
                "url": "https://finnhub.io/api/news?id=410db8182804b6303abecfdda33650968aec0f21b03cd9a3d8bc4ae9c9c32635",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Globus Medical will report Q2 results on Aug. 6. Investors will be keen to know whether Enabling Technologies and Spine strength aid revenue & earnings growth.",
                "category": "company",
                "datetime": 1785518640,
                "headline": "GMED's Q2 Earnings on Deck: Will Enabling Technologies Lead Results?"
              },
              {
                "id": 141078993,
                "url": "https://finnhub.io/api/news?id=20a75c1e9091041914218ad2349141d379e846b8809bc2b23e5f3e9cc9ab55a3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Millions of Medicare Advantage members will open a letter this fall that could quietly close doors they assume will always stay open. What insurers have already decided for 2027 and what enrollees do next could cost thousands of dollars or make coverage impossible to find.",
                "category": "company",
                "datetime": 1785510282,
                "headline": "Medicare Advantage Insurers Are Redrawing the Map for 2027. Members Find Out by Letter This Fall."
              },
              {
                "id": 141078994,
                "url": "https://finnhub.io/api/news?id=2b219a3e77c8f6e358fd5153e8682484795f8313cb8697de0c73ce586ddea8a5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The lever behind UnitedHealth stock's climb was a Medicare Advantage repricing management had described months before the run began, and the hard part was believing a plan whose author had just been wrong.",
                "category": "company",
                "datetime": 1785508598,
                "headline": "UnitedHealth Stock Ran On A Repricing The Company Described In Advance"
              },
              {
                "id": 141079088,
                "url": "https://finnhub.io/api/news?id=7f4c271b442c986f9fc0f3c55d4b7550e25993bc41527456cb305dd18e5def24",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
                "category": "company",
                "datetime": 1785504602,
                "headline": "Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?"
              },
              {
                "id": 141079089,
                "url": "https://finnhub.io/api/news?id=4a3feacc19b28ea4feb7f74f8cc876a774fcf71820cd76b338968d06f2af72d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Beyond analysts' top-and-bottom-line estimates for CVS Health (CVS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.",
                "category": "company",
                "datetime": 1785503706,
                "headline": "Stay Ahead of the Game With CVS Health (CVS) Q2 Earnings: Wall Street's Insights on Key Metrics"
              },
              {
                "id": 141071591,
                "url": "https://finnhub.io/api/news?id=2836594e64296607bb7f6e294cf33070ec4c9783ecab2f8b748f782468ecb239",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The telehealth company is making a bold pivot that's driving growth, but the stock's recent slide has investors wondering if the price of admission is still too high.",
                "category": "company",
                "datetime": 1785447512,
                "headline": "Is The Sharp Drop In Hims & Hers Health Stock A Reason To Buy?"
              },
              {
                "id": 141069851,
                "url": "https://finnhub.io/api/news?id=4b814b8b29302525729aa99abc8230d89bf36a9bf2793991411ceb3f8906f174",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Add another member to the fast-and-furious AI unicorn club: Simile",
                "category": "company",
                "datetime": 1785433811,
                "headline": "Synthetic-user startup Simile raises $200M at $2B valuation 5 months after $100M Series A"
              },
              {
                "id": 141069852,
                "url": "https://finnhub.io/api/news?id=386a60c4175b7abbbd17001351c4bf87e46acc6e1264303741f9877b999c3b4a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CRL is set to report Q2 results on Aug. 5 as investors watch segment demand, divestitures, and whether the company can extend its earnings beat streak.",
                "category": "company",
                "datetime": 1785432540,
                "headline": "Charles River Prepares to Report Q2 Earnings: What's in Store?"
              },
              {
                "id": 141068399,
                "url": "https://finnhub.io/api/news?id=33e70b42c10ebea81c86727fe6079c0c515c1914256ae2789b81e00ac74af362",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Knorr-Bremse AG (KNRRY) achieves highest quarterly operating EBIT margin in five and a half years, while launching a 'Growth Beyond' strategy targeting EUR10 billion in revenue by 2030.",
                "category": "company",
                "datetime": 1785430970,
                "headline": "Knorr-Bremse AG (KNRRY) (Q2 2026) Earnings Call Highlights: Record EBIT Margin and Ambitious ..."
              },
              {
                "id": 141066825,
                "url": "https://finnhub.io/api/news?id=7732df3bfba8e8792d4b9441da85f3c53afc88c090e5320f2e16b7acd62f7f3e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "WOONSOCKET, RI / ACCESS Newswire / July 30, 2026 /Originally published on CVS Health Company Newsroom CVS Health® (NYSE:CVS) today announced that it has been named Overall Winner and earned four gold awards at the 2026 US Customer Experience Awards ...",
                "category": "company",
                "datetime": 1785421800,
                "headline": "CVS Health(R) Named Overall Winner and Wins Four Gold Awards at 2026 US Customer Experience Awards"
              },
              {
                "id": 141066826,
                "url": "https://finnhub.io/api/news?id=971c787ccfe80e044086989bf55b5f290d451c2c99c0681c7a97d62a0135e510",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Viatris (VTRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1785420007,
                "headline": "Viatris (VTRS) Q2 Earnings Preview: What's in the Cards?"
              },
              {
                "id": 141065559,
                "url": "https://finnhub.io/api/news?id=d62e31e897d4f433a00b20a8659004378f9c18d359be9660411503db006584b3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health® (NYSE: CVS) today announced that it has been named Overall Winner and earned four gold awards at the 2026 US Customer Experience Awards (USCXA26), the country's premier independent recognition program for CX excellence.",
                "category": "company",
                "datetime": 1785416400,
                "headline": "CVS Health® named Overall Winner and wins four gold awards at 2026 US Customer Experience Awards"
              },
              {
                "id": 141065560,
                "url": "https://finnhub.io/api/news?id=9d94e902e7ed604d85d6fe83230bf12491391d1ef80fdd3d84982137b4bc9673",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "NORTHAMPTON, MA / ACCESS Newswire / July 30, 2026 / CVS Health Originally published on CVS Health Company Newsroom Key points SPF is becoming a daily wellness essential The top SPF myths consumers still believe What shoppers are looking for in SPF ...",
                "category": "company",
                "datetime": 1785414600,
                "headline": "CVS Health: SPF Learnings From the Whole-Body Beauty Brief: SPF Edition"
              },
              {
                "id": 141054221,
                "url": "https://finnhub.io/api/news?id=473ef4c4d07b4e0c09b4494d1f0b1ef1f9a21934fd323610a282865861a7b788",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "X sued the WFA in 2024 for conducting what it called a \"systematic illegal boycott\" of the platform after it saw a decline in advertising revenue following Musk's $44 billion takeover of the social network",
                "category": "company",
                "datetime": 1785339408,
                "headline": "Elon Musk’s X settles multiyear legal battle with the World Federation of Advertisers"
              },
              {
                "id": 141054222,
                "url": "https://finnhub.io/api/news?id=057435499cfe4a8d482a308ee99f77217bb24b0ce3840171f1c0869ab36a6045",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "SpaceX's X and the World Federation of Advertisers (WFA) said on Wednesday they had settled litigation ‌over an alleged advertiser boycott of the social media ‌platform linked to the now-defunct Global Alliance for Responsible Media (GARM).  The move marks a ​reset in relations between Elon Musk's social media platform and the advertising trade body.  The announcement follows a March ruling in which a U.S. judge dismissed X's antitrust lawsuit accusing the WFA and ‌major companies, including Mars, ⁠CVS Health and Colgate-Palmolive of orchestrating an illegal boycott of the platform.",
                "category": "company",
                "datetime": 1785337551,
                "headline": "X, World Federation of Advertisers settle litigation over GARM dispute"
              },
              {
                "id": 141059784,
                "url": "https://finnhub.io/api/news?id=b191e7c888bc9c4000d9aa2a8c6d8d4c8cebfa5e7aae09f2a01bbf4cf6626c3a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "X's lawsuit against the nonprofit organization incited wider debate about the influence that advertisers may be able to exert on right-leaning media.",
                "category": "company",
                "datetime": 1785336682,
                "headline": "Elon Musk's X and WFA End Multiyear Legal Spat"
              },
              {
                "id": 141054223,
                "url": "https://finnhub.io/api/news?id=454b3fdb0e0580e74dd21111d0d59e932caffd490262e256c2594b05d71cff11",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "WOONSOCKET, RI / ACCESS Newswire / July 29, 2026 /Originally published on CVS Health Company Newsroom Health100™, a CVS Health® subsidiary, announced today it has earned the CARIN Code of Conduct for Consumer-Facing Applications Accreditation from ...",
                "category": "company",
                "datetime": 1785334800,
                "headline": "CVS Health: Health100(TM) Earns Industry Accreditation for Consumer Data Privacy and Security"
              },
              {
                "id": 141054224,
                "url": "https://finnhub.io/api/news?id=43b5f59e24013e85fcec60fb83e0dc40acebb2bce4a3bdf47b1fe522cb3ad553",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1785333622,
                "headline": "CVS Health (CVS) Earnings Expected to Grow: Should You Buy?"
              },
              {
                "id": 141053117,
                "url": "https://finnhub.io/api/news?id=b1d799f63725de290ebb65e2024562fdf8a9f89bb69f245fb4d7f0c37d3a84cd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Health100™, a CVS Health® subsidiary, announced today it has earned the CARIN Code of Conduct for Consumer-Facing Applications Accreditation from DirectTrust® for the Health100 mobile app.",
                "category": "company",
                "datetime": 1785330000,
                "headline": "Health100™ Earns Industry Accreditation for Consumer Data Privacy and Security"
              },
              {
                "id": 141053116,
                "url": "https://finnhub.io/api/news?id=cdd075e89bddbd2c16a122d0e1447dce040487ab82bb8d142e3953bd92d7743e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "WOONSOCKET, RI / ACCESS Newswire / July 29, 2026 /Originally published on CVS Health Company Newsroom CVS Health® (NYSE:CVS) announced that common prescription medications for dogs and cats are now available at its approximately 9,000 CVS Pharmacy® ...",
                "category": "company",
                "datetime": 1785330000,
                "headline": "Pet Medications Now Available at CVS Pharmacy(R)"
              },
              {
                "id": 141054225,
                "url": "https://finnhub.io/api/news?id=41aa526220e6ca239ab5014e1a1a76b5e395a007395bd137b135590ae8524e63",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "ZBH heads into Q2 earnings with expectations of modest revenue growth as investors watch demand trends across knees, hips and robotics.",
                "category": "company",
                "datetime": 1785329880,
                "headline": "Zimmer Biomet Set to Report Q2 Earnings: What's in the Cards?"
              },
              {
                "id": 141052151,
                "url": "https://finnhub.io/api/news?id=f5f80e1ed7da3428606a70bdff1c7fd73533b4a7d1c50efe913c1d9f8efe01c6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Humana reports a higher medical cost ratio and reaffirms, rather than raises, its full-year earnings guidance.",
                "category": "company",
                "datetime": 1785320640,
                "headline": "Why Humana Stock Is Falling After Earnings Beat Expectations"
              },
              {
                "id": 141052060,
                "url": "https://finnhub.io/api/news?id=d54917c46297de545bf1c83039a6021456a950e88e9510b0c22ac135d6fe1e9a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "(Bloomberg) -- Executives and investors tied to the AI supply chain were among the biggest insider sellers in the second quarter, taking advantage of a sharp — and volatile — rally in technology stocks.Most Read from BloombergUS Intercepts Iran Attack on Bases, Puncturing Days of CalmSK Hynix Profit Disappoints, Spending Soars to $31 BillionNvidia’s $750 Billion in Deals Reignite Circular AI FearsChip Rout Deepens on Circular Funding, China Competition FearsApple Set to Make Big Smart Home Push",
                "category": "company",
                "datetime": 1785317401,
                "headline": "AI Boom Spurs Insider Selling by Nvidia, CoreWeave Billionaires"
              },
              {
                "id": 141050683,
                "url": "https://finnhub.io/api/news?id=a2d5433a491fe3da53362b4c361899eb96256bc15e600261570c37aea5a0acc6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health opened new pharmacy focused CVS Pharmacy locations in smaller, neighborhood formats across the United States. The company began offering the Kate Farms High Protein Nutrition Shake on shelves nationwide in CVS stores. These moves expand CVS Health's physical footprint and its presence in the wellness and nutrition category. CVS Health (NYSE: CVS) is adding fresh operational moves on top of a strong recent share price run. The stock trades at $109.34 and is up 36.5% year to date,...",
                "category": "company",
                "datetime": 1785299313,
                "headline": "CVS (NYSE:CVS) Opens Pharmacy Focused Stores And Brings Kate Farms Nationwide"
              },
              {
                "id": 141048341,
                "url": "https://finnhub.io/api/news?id=abd391d3aed97822ea91e076fe032c0fea6b4a3a34b1618385e9c25aa52da4d1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health (CVS) closed the most recent trading day at $109.34, moving +2.12% from the previous trading session.",
                "category": "company",
                "datetime": 1785275103,
                "headline": "CVS Health (CVS) Laps the Stock Market: Here's Why"
              },
              {
                "id": 141048342,
                "url": "https://finnhub.io/api/news?id=8bebc18e1f1503273259d561acec47a4a70123174d00e131b248fbc239f37448",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Administration officials told the Wall Street Journal that the subsidy program that has helped suppress Medicare Part D prescription drug plan premiums will not be renewed for 2027.",
                "category": "company",
                "datetime": 1785274910,
                "headline": "CNC, UNH, CVS, HUM Stocks Slip After-Hours — Trump Administration Reportedly Seeks To Scrap Subsidies On Certain Medicare Plans"
              },
              {
                "id": 141047520,
                "url": "https://finnhub.io/api/news?id=767a0ad3952bb7b868fb1f62d557f9a17b181295616fba5184029f792f9359ee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Humana reports earnings Wednesday after its stock surged this year on improving confidence in Medicare Advantage insurers. Investors will be watching medical costs and the company’s outlook.",
                "category": "company",
                "datetime": 1785271080,
                "headline": "Humana Earnings Face High Expectations as Medicare Advantage Recovers"
              },
              {
                "id": 141045336,
                "url": "https://finnhub.io/api/news?id=24eab49ae0a53c20e5b57026e08c3e4bf6d6f9d32585f4bd8b0d5b91489e8512",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "WOONSOCKET, RI / ACCESS Newswire / July 28, 2026 /Originally published on CVS Health Company Newsroom CVS Health® (NYSE:CVS) - highlighted its continued investments in improving the health of communities across Massachusetts, spanning affordable housing, ...",
                "category": "company",
                "datetime": 1785255300,
                "headline": "CVS Health Helping To Strengthen Communities Across Massachusetts"
              },
              {
                "id": 141046976,
                "url": "https://finnhub.io/api/news?id=ee99550e65d283f8fc6944965013ad47621413e2f6544d5e671d18f30d079119",
                "image": "",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "https://www.wsj.com/health/healthcare/trump-administration-to-end-medicare-drug-plan-subsidy-76d255d1",
                "category": "company",
                "datetime": 1785254534,
                "headline": "'Trump Administration To End Medicare Drug Plan Subsidy; Program That Held Down Premiums Not Renewed For 2027, Resulting In Higher Costs For Some Seniors' - WSJ Exclusive"
              },
              {
                "id": 141043753,
                "url": "https://finnhub.io/api/news?id=26ad68828352e6c29c891a3dfad45b0b89d2bac7a4cc44630baee9cb00c94ea1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "HSIC heads into Q2 earnings with expectations for revenue and EPS growth as dental, specialty products and AI-enabled technology remain in focus.",
                "category": "company",
                "datetime": 1785245100,
                "headline": "Henry Schein Prepares to Report Q2 Earnings: What's in the Cards?"
              },
              {
                "id": 141046377,
                "url": "https://finnhub.io/api/news?id=2e6a2cdd87cb0a2c43f8b71b5601a07a07499ef53d3bafce15f9dd767a03d3a8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health has rallied the broader market over the past year, and analysts remain highly optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1785242040,
                "headline": "Do Wall Street Analysts Like CVS Health Stock?"
              },
              {
                "id": 141042518,
                "url": "https://finnhub.io/api/news?id=b1a655064c5d5da398a0e6328dc687b565276056052016f91150c05f2a1cd152",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Kate Farms, the #1 doctor-recommended plant-based brand1, today announced continued national retail expansion of its High Protein Nutrition Shake (HPNS), including expanded distribution at Walmart and a new launch into CVS. The foundational nutrition brand also unveiled Vanilla, the newest flavor in its growing HPNS lineup, as Kate Farms continues expanding beyond traditional medical nutrition channels to meet broader everyday health needs.",
                "category": "company",
                "datetime": 1785240000,
                "headline": "Kate Farms Expands High Protein Nutrition Shake Into Walmart and CVS as Retail Distribution Grows Sevenfold"
              },
              {
                "id": 141041785,
                "url": "https://finnhub.io/api/news?id=05331852a7fabd0d89cd994e30b93d517cda0768c3cccd460d522c8400fc7c69",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS, CAH, HUM and ACAD show favorable earnings indicators ahead of Q2 results as healthcare demand stays resilient despite margin pressures.",
                "category": "company",
                "datetime": 1785229320,
                "headline": "The Zacks Analyst Blog Highlights CVS Health, Cardinal Health, Humana and ACADIA Pharmaceuticals"
              },
              {
                "id": 141041105,
                "url": "https://finnhub.io/api/news?id=d2b916e85b8c8418c14e0dbe6d6de84dea5ecd94ca2423a114841f56d47e1e85",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "How three generations of retail experience helped shape one of America's most recognized distribution careers, from neighborhood beginnings in Brooklyn to partnerships with Walmart, Costco, CVS, Walgreens, Amazon, and internationally recognized brands. ...",
                "category": "company",
                "datetime": 1785229200,
                "headline": "From Brooklyn Family Roots to America's Retail Giants: Mitch Gould's Three-Decade Journey"
              },
              {
                "id": 141037136,
                "url": "https://finnhub.io/api/news?id=1962630925adf572941ee3d09545871641e85445ce685d06cecba1d3bddbddb1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "UNH's post-earnings pullback follows a 52-week high, as stronger guidance offsets Medicaid pressures and spotlights healthcare ETFs with sizable exposure.",
                "category": "company",
                "datetime": 1785180480,
                "headline": "UnitedHealth Pulls Back Post 52-Week High: Healthcare ETFs to Watch"
              },
              {
                "id": 141035163,
                "url": "https://finnhub.io/api/news?id=bf2a863d652d53f3f0e7f81e306d5e117f2cf971706058641724c857d5910e94",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "PITTSBURGH, July 27, 2026--MFA presented an analysis of the top administrators for MD using new comparison tools found only in MFA’s ASO Employer Health plus (AEHP) product.",
                "category": "company",
                "datetime": 1785171780,
                "headline": "Leading Maryland Administrative Services Only Health Plans Assessed by Mark Farrah Associates"
              },
              {
                "id": 141035247,
                "url": "https://finnhub.io/api/news?id=3ce6310c5a7787015ebdff11b4a2487d30095a481eeaf725620e2ed8721805d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS, CAH, HUM and ACAD look ready for Q2 2026 earnings beats as growing demand for medical products and services continues to support performance.",
                "category": "company",
                "datetime": 1785168180,
                "headline": "4 Medical Stocks With the Right Setup for Q2 Earnings Beats"
              },
              {
                "id": 141031502,
                "url": "https://finnhub.io/api/news?id=c419ae20619cf861bede1e5f0d2a22e1c067edad353d338793742330036f07e3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "(Bloomberg) -- US companies that are integrating artificial intelligence capabilities are well positioned this earnings season as they’re poised for stronger profit margins, according to Morgan Stanley strategists.Most Read from BloombergDeepSeek Suspends Fundraising After Viral US-China PostsUS, Iran Extend Pause in Strikes as Oman Holds Hormuz TalksSpaceX at $100 Would Imply Zero AI Value, Morgan Stanley SaysChina Chipmaker CXMT Jumps 466% in Debut After Blockbuster IPOStocks, Bonds Rise in Re",
                "category": "company",
                "datetime": 1785144285,
                "headline": "Morgan Stanley’s Wilson Says AI Adoption Key to Profit Outlook"
              },
              {
                "id": 141024010,
                "url": "https://finnhub.io/api/news?id=2c5db92c8ab827ee6f3b90cbf33fde6ea6c56be2eb02d39168027e8407bb46f0",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/803420378/image_803420378.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CVS",
                "summary": "The series targets generating 12–15% annualized income through disciplined selling of PUT and BUY-WRITE CALL options on large-cap stocks. Check out the strategy here.",
                "category": "company",
                "datetime": 1785053700,
                "headline": "Earn 10-15% Potential Income: Monthly Options Series (Aug. 2026)"
              },
              {
                "id": 141010629,
                "url": "https://finnhub.io/api/news?id=72c1ecc8070e3542fabff6ca1bb5afaef92eb2cf19bd4772f53eb42130f87fc5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "They are riding strong tailwinds that could lift them higher.",
                "category": "company",
                "datetime": 1784928000,
                "headline": "These 3 Healthcare Stocks Have Crushed the Market This Year. Here's Why There's More Upside Ahead"
              },
              {
                "id": 141010762,
                "url": "https://finnhub.io/api/news?id=34cf0495c3aad32ad59c71b73880c9d0cf75062d6a008f74ecd1fff6c757b090",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The healthcare giant looks expensive on today's numbers, but a patient investor is effectively buying it at a significant discount to that price.",
                "category": "company",
                "datetime": 1784926584,
                "headline": "The Real Price of UnitedHealth Stock Is Two Years Away"
              },
              {
                "id": 141007898,
                "url": "https://finnhub.io/api/news?id=4e1b2df29b10a81eb5b7242e1dd9bf833179ad3e79e293a12a1feb8308f4a946",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "HCA tops Q2 EPS estimates on higher admissions and revenue per admission but trims parts of its 2026 guidance as higher expenses and weaker surgical volumes weigh on results.",
                "category": "company",
                "datetime": 1784908020,
                "headline": "HCA Q2 Earnings Beat on Strong Admissions, 2026 Outlook Revised"
              },
              {
                "id": 141006514,
                "url": "https://finnhub.io/api/news?id=2148563f0fd1def37b0d2f484ae47f6acccb5f95dfe8168ac3c11b15ec31941f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
                "category": "company",
                "datetime": 1784898903,
                "headline": "Medpace Holdings, Inc. (MEDP) Hit a 52 Week High, Can the Run Continue?"
              },
              {
                "id": 141004342,
                "url": "https://finnhub.io/api/news?id=487694cc9102f723e44ba26365bb9874f77b3b0c868ecddce5f5388faa57defa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health stock has surged nearly 80% in a year while the quarterly dividend has sat frozen for ten straight quarters, raising a pointed question for income investors: is this pause a sign of discipline or a warning.",
                "category": "company",
                "datetime": 1784891720,
                "headline": "How Safe Is CVS Health’s Dividend?"
              },
              {
                "id": 141004492,
                "url": "https://finnhub.io/api/news?id=77829394a058430084fb8719da01b32de48fa17da09484f57925a7b4fe26c0b1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.",
                "category": "company",
                "datetime": 1784890628,
                "headline": "3 Unpopular Stocks We Find Risky"
              },
              {
                "id": 141000903,
                "url": "https://finnhub.io/api/news?id=eaec161b72ea970f2ddba6aa28ab20062f52af3acda933223d12e2e36a1cb19f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Henry Ford Health has filed a lawsuit against CVS Health (NYSE:CVS) alleging fraudulent reimbursement practices tied to the federal 340B drug discount program. The complaint claims CVS manipulated pricing and engaged in retaliatory behavior, which Henry Ford Health says led to losses of more than US$29 million. The case adds to a series of disputes between large health systems and pharmacy operators over how 340B program discounts are administered. For investors following CVS Health, this...",
                "category": "company",
                "datetime": 1784848585,
                "headline": "CVS Health (CVS) Faces Henry Ford Health Lawsuit Over $29 Million 340B Claims"
              },
              {
                "id": 141000904,
                "url": "https://finnhub.io/api/news?id=945d8f5b483d11950bb0f865f5027dfdad06c1441c00627c70672b24b75ddc32",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health is in focus after a modest reset to its price target framework, with the updated intrinsic value estimate moving from US$107.73 to US$111.92, a change of about 3.9%. This shift sits alongside Street commentary that ties higher price objectives to views on Medicare Advantage execution, pharmacy and pharmacy benefit manager performance, and GLP-1 related efforts, while still flagging policy and utilization trends as key swing factors. As you read on, you will see how these evolving...",
                "category": "company",
                "datetime": 1784844598,
                "headline": "CVS Health (CVS) Stock Sees Modest Fair Value Lift As Analysts Raise Targets"
              },
              {
                "id": 140997787,
                "url": "https://finnhub.io/api/news?id=62fce0608d45e410c0de9b5328f24b3e6e5af974a2273c77868794b05275e66a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Molina beats Q2 earnings estimates as lower operating expenses offset weaker premium revenues, declining membership and softer investment income, while the company raises its 2026 earnings guidance.",
                "category": "company",
                "datetime": 1784830020,
                "headline": "MOH Q2 Earnings Beat on Lower Operating Expenses, 2026 EPS View Raised"
              },
              {
                "id": 140997788,
                "url": "https://finnhub.io/api/news?id=83e354d6ff676bef0a49d10fc0c1b54696db4c0232248a51e0774c382122e7ce",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Group (LON:CVSG) said revenue for the financial year ended June 30 exceeded GBP 710 million, up 5.9% from the prior year, as the veterinary services provider used an investor presentation to reiterate its capital allocation policy and outline expected returns from acquisitions and capital invest",
                "category": "company",
                "datetime": 1784822856,
                "headline": "CVS Group Q4 Earnings Call Highlights"
              },
              {
                "id": 140994770,
                "url": "https://finnhub.io/api/news?id=299ad99206bde91116b20e6b24304421573db0812f8ba7d6e8850c19292f9e03",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
                "category": "company",
                "datetime": 1784811604,
                "headline": "CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know"
              },
              {
                "id": 140995370,
                "url": "https://finnhub.io/api/news?id=02e166969dac9e5bf05ceddb9e29879f8044e8385717770a1b15e18c5a0bd85e",
                "image": "",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "https://www.bloomberg.com/news/articles/2026-07-23/telehealth-firms-urge-fda-to-legalize-peptides-with-guardrails",
                "category": "company",
                "datetime": 1784801644,
                "headline": "'Telehealth Firms Urge FDA to Legalize Peptides, With Guardrails' - Bloomberg"
              },
              {
                "id": 140989328,
                "url": "https://finnhub.io/api/news?id=58fcc53d8c16c18d46f0ec27cdeb69edf7c627bc7e5c1afa8d45504d98483023",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Memorial Healthcare System and Aetna, a CVS Health company, have renewed a multi-year agreement ensuring Aetna members continue to have in-network access to Memorial's high-quality hospitals, physicians and specialty services throughout South Florida.",
                "category": "company",
                "datetime": 1784760900,
                "headline": "Memorial Healthcare System and Aetna Renew Multi-Year Agreement"
              },
              {
                "id": 140984829,
                "url": "https://finnhub.io/api/news?id=2f2272d9552f91dafd6d7c831974c5bf8ef9427b82e62af9094030a2b682c978",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Victory Capital, overseeing the RS Large Cap Value Strategy, released its Q2 2026 investor letter. A copy of the letter can be downloaded here. The RS Large Cap Value Strategy underperformed the Russell 1000 Value Index in the second quarter of 2026 as unfavorable stock selection and sector allocation weighed on relative performance. U.S. equities remained […]",
                "category": "company",
                "datetime": 1784736220,
                "headline": "CVS Health Corporation (CVS) Rose on Improving Execution and Payer Margin Outlook"
              },
              {
                "id": 140981940,
                "url": "https://finnhub.io/api/news?id=4ef76ce27eda81d626046a0e4578b307154512d58d22f0a60cb0d85499f4330a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "LH heads into Q2 earnings results with expectations for higher revenues and EPS, as diagnostics, specialty testing and new collaborations drive momentum.",
                "category": "company",
                "datetime": 1784723820,
                "headline": "Labcorp Prepares to Report Q2 Earnings: What's in the Cards?"
              },
              {
                "id": 140981932,
                "url": "https://finnhub.io/api/news?id=fab036acb6e9446c3c49c28f35c20bbc11ddac44b4ef5558635037c4605b8032",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Healthcare is quietly stealing the spotlight from mega cap tech in 2026, and two S&P 500 giants are trading at valuations that suggest the market has not caught on yet.",
                "category": "company",
                "datetime": 1784721621,
                "headline": "2 Absurdly Cheap Healthcare Stocks to Buy Before July Ends"
              },
              {
                "id": 140978863,
                "url": "https://finnhub.io/api/news?id=6b4d9a360f989ba582f7ca97a2d6c8164da18eb257639bdd8a448d995aa02745",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Investors showed confidence in healthcare improvements, strong biotech patents, and rising packaging demand.",
                "category": "company",
                "datetime": 1784689652,
                "headline": "Why Did CVS, URGN, CCK Stocks Hit 52-Week Highs Today?"
              },
              {
                "id": 140977714,
                "url": "https://finnhub.io/api/news?id=6204d440400628ca4bd8f10667a9197e6e9e311b906d21700bd5d149772e726e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The latest trading day saw CVS Health (CVS) settling at $110.6, representing a +2.78% change from its previous close.",
                "category": "company",
                "datetime": 1784670303,
                "headline": "CVS Health (CVS) Surpasses Market Returns: Some Facts Worth Knowing"
              },
              {
                "id": 140976384,
                "url": "https://finnhub.io/api/news?id=57236c5052f85582eb5ea0f555f013f41560f1273e2f5734bc67c62a45028091",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Investors are rightly focused on the company's Medicaid struggles, but the real upside story may be hiding in plain sight across the rest of its business.",
                "category": "company",
                "datetime": 1784669171,
                "headline": "The Hidden Engine Behind Elevance Health Stock's Next Climb"
              },
              {
                "id": 140976385,
                "url": "https://finnhub.io/api/news?id=82aea808c7ba6dd8cc4c52c74c0cbb24ac81eca4dffdd8eaae25d25ec6adcf2e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "UnitedHealth's stock is flying high after it raised guidance, but on its latest earnings call, analysts zeroed in on an underlying margin divergence running right through the business.",
                "category": "company",
                "datetime": 1784665995,
                "headline": "What Kept Coming Up When Analysts Grilled UNH"
              },
              {
                "id": 140973415,
                "url": "https://finnhub.io/api/news?id=0bd242c66006a6bff3ef5c4ed8e2fa59aa85dcc5cf5257c89b974529dd6b6ca8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "DHR beats Q2 estimates as Life Sciences posts its strongest quarter in years, prompting the company to raise its 2026 adjusted EPS outlook.",
                "category": "company",
                "datetime": 1784648040,
                "headline": "Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y"
              },
              {
                "id": 140970564,
                "url": "https://finnhub.io/api/news?id=11687722f07d513773e7d9dd22888488c26ee4999d1e316633f790338596cf83",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health® (NYSE: CVS) today announced that common prescription medications for dogs and cats are now available at its approximately 9,000 CVS Pharmacy® locations nationwide. Pet owners can fill prescriptions for select pet-only medications, including antibiotics, allergy, flea and tick control, insulin, and pain relievers, at their local CVS Pharmacy, expanding access to essential pet health care. Greater flexibility in where pet prescriptions are filled helps reduce stress and delays, ensurin",
                "category": "company",
                "datetime": 1784638800,
                "headline": "Pet medications now available at CVS Pharmacy®"
              },
              {
                "id": 140964592,
                "url": "https://finnhub.io/api/news?id=58f2422d303d8abfa6b6a25d4132328b6a814c3f9522481f3742d3a550f5e74e",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/20/Medicare-Advantage.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "Losing a health plan is stressful at any age. Losing it in retirement, when a familiar doctor and a specific drug list are woven into daily life, is worse. Yet that is exactly what happened to a large group of older",
                "category": "company",
                "datetime": 1784568273,
                "headline": "2.6 Million People Lost Their Medicare Advantage Plan This Year: Here's How To Avoid Being Caught Off Guard For 2027"
              },
              {
                "id": 140962201,
                "url": "https://finnhub.io/api/news?id=cee1f0ffc47f5fe9ae7df305cd526cd47c23b2dff66f34a00cdffd2c1097c321",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "You may not have bought this single stock, but your funds quietly made it one of your biggest positions.",
                "category": "company",
                "datetime": 1784566599,
                "headline": "How Much CVS Stock Are You Really Betting On?"
              },
              {
                "id": 140960646,
                "url": "https://finnhub.io/api/news?id=26611f7250ba7764b0a74ecf69e8ba7e9451005d8c6eacbd3be4626ede25f15c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The stock is trading near 52-week highs, but under the surface, commercial segment cost trends are creating headwinds.",
                "category": "company",
                "datetime": 1784558582,
                "headline": "The Real Risk Inside UnitedHealth Stock"
              },
              {
                "id": 140959625,
                "url": "https://finnhub.io/api/news?id=da9274a0fe0cbdd8f27a070ffb232605588f80d80e29c2cf30824f34cb50b4f0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.",
                "category": "company",
                "datetime": 1784552613,
                "headline": "2 Large-Cap Stocks on Our Buy List and 1 Facing Challenges"
              },
              {
                "id": 140961278,
                "url": "https://finnhub.io/api/news?id=8933741492c1d0479219204df9781b5a6c9b7c335bea6f8b7660ef6c8e21e7ef",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1401250676/image_1401250676.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CVS",
                "summary": "CVS Health turnaround update: improving margins, cash flow and EPS outlook—but valuation looks richer. Read the latest analysis on the stock and the upcoming Q2 earnings print here.",
                "category": "company",
                "datetime": 1784549506,
                "headline": "CVS Health Update: The C- Student Now Pulling Down A B+"
              },
              {
                "id": 140939166,
                "url": "https://finnhub.io/api/news?id=abb851b8ee2d464a110b910c89dadec490fc80b6db6ddf24abbb5c7ae870adf5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The sticker price on CVS shares looks high, but the real question is what it costs on the earnings expected two years from now.",
                "category": "company",
                "datetime": 1784326192,
                "headline": "What A Patient Holder Is Really Paying For CVS Health Stock"
              },
              {
                "id": 140939174,
                "url": "https://finnhub.io/api/news?id=50dc6e76d1c3aa89467680e6bc1cf51c7a2b8faf7bea9022ea161510d8c648b1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The health insurer raised its forecast after a solid quarter, but investors focused on the one business so broken it’s forcing a strategic retreat.",
                "category": "company",
                "datetime": 1784325720,
                "headline": "What's A Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets?"
              },
              {
                "id": 140936386,
                "url": "https://finnhub.io/api/news?id=a6e75d38dfff88fda97d4ce086ca14abacf40e926de421c6195cf3c77fd8a2b5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health opened its first new pharmacy focused CVS Pharmacy in Houston, introducing a neighborhood format aimed at expanding access to pharmacy care. The company plans to roll out nearly 20 similar locations across the U.S., including additional sites in the Houston area. This move is part of CVS Health's effort to realign its retail footprint and respond to changing consumer preferences for in person pharmacy services. For investors tracking NYSE:CVS, the launch of this new format comes...",
                "category": "company",
                "datetime": 1784311971,
                "headline": "CVS Health (CVS) Opens Its First Neighborhood Pharmacy In Houston"
              },
              {
                "id": 140936387,
                "url": "https://finnhub.io/api/news?id=1d482b41cd65bfeeff328c1f76f4f34ba9a93320a320b5b1be9070e9c53e9be1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Insurance carriers need more proof that paying today’s GLP-1 drug prices will create “enough downstream savings,” assuming that people are healthier long term.",
                "category": "company",
                "datetime": 1784311200,
                "headline": "CVS Health CEO David Joyner warns private insurers won't cover GLP-1s for weight loss until drug prices drop"
              },
              {
                "id": 140934563,
                "url": "https://finnhub.io/api/news?id=b725855cd4ad0fb8ad226bb5bb42684fa22ff99ebe0aa63c26f1cb7cfebd8568",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health® (NYSE: CVS) today unveiled its first pharmacy-focused CVS Pharmacy® in Houston. The new pharmacy, located at 8503A Gulf Freeway in south Houston, will help bridge gaps in pharmacy care and make it easier for community members to access medications, immunizations and other health care services provided by pharmacists.",
                "category": "company",
                "datetime": 1784304000,
                "headline": "CVS Pharmacy® celebrates opening of first pharmacy-focused location in Houston"
              },
              {
                "id": 140931695,
                "url": "https://finnhub.io/api/news?id=9788306605ef918ef57fbb3d01751657b46bf0d0fd30885bd07c373adad003d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "You didn't buy this single stock, but after a powerful run, your favorite ETF might have made a big bet on it for you.",
                "category": "company",
                "datetime": 1784291132,
                "headline": "How Much Of Your Portfolio Is Really CVS?"
              },
              {
                "id": 140929126,
                "url": "https://finnhub.io/api/news?id=12c4d7fb8ca1860aec13bba87e9e2bafbdf4c635db390bd1ee8e39b9f3dc3cc5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health stock has climbed sharply over the past year, yet its valuation checks lean expensive. This puts the recent share price strength under closer scrutiny for anyone considering the current upside from here. Over the last 1 year, CVS Health has returned 74.4%, a strong run that raises the bar for what future performance needs to justify at today’s price. Regulatory settlements around pharmacy benefit management and past compliance issues can remove some overhang but also highlight...",
                "category": "company",
                "datetime": 1784265014,
                "headline": "CVS Health (CVS) Stock Looks Pricey On FTC Insulin Settlement"
              },
              {
                "id": 140928686,
                "url": "https://finnhub.io/api/news?id=ce154cdc9d5df71e254f5614f33a67f001c75a2374bc51fc020ddb8972987c97",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Earlier this month, CVS Health’s board approved a quarterly dividend of US$0.665 per share, payable on August 3, 2026, to shareholders of record as of July 23, 2026, while Aetna leadership highlighted the clinical importance of GLP‑1 weight-loss drugs for diabetes and obesity care. Together with improving provider‑payer trust at Aetna and upbeat analyst research, management’s focus on GLP‑1 access and support has reinforced perceptions of CVS Health’s evolving role across insurance,...",
                "category": "company",
                "datetime": 1784258895,
                "headline": "How Investors May Respond To CVS (CVS) Dividend Move And GLP‑1 Strategy Across Its Health Platform"
              },
              {
                "id": 140926098,
                "url": "https://finnhub.io/api/news?id=a3ed218800a97680c73e07aa6bb488836ce3c983719dca490e71b4cd424977f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Stronger medical costs and better-than-expected quarterly profit lifted guidance and boosted confidence in the earnings recovery.",
                "category": "company",
                "datetime": 1784233476,
                "headline": "UnitedHealth Jumps 10.3% After Raising 2026 EPS Outlook Above Estimates"
              },
              {
                "id": 140922761,
                "url": "https://finnhub.io/api/news?id=5c8b91a10f59cacf4ca9e21f467d05259ae902f69ce878fc4970cd452cbb654f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Community Health heads into Q2 earnings with mixed operating trends as stronger occupancy meets lower admissions and a smaller hospital portfolio.",
                "category": "company",
                "datetime": 1784220780,
                "headline": "Can Higher Occupancy Offset Lower Admissions in CYH's Q2 Earnings?"
              },
              {
                "id": 140922751,
                "url": "https://finnhub.io/api/news?id=064695c2c7c73e8c795a57647a68b4874cbf622ad91f18be92ec15c915686b53",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "ABT tops Q2 earnings and revenue estimates and lifts 2026 EPS guidance, while Medical Devices and Cancer Diagnostics fuel growth despite Nutrition weakness.",
                "category": "company",
                "datetime": 1784217000,
                "headline": "Abbott Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-market"
              },
              {
                "id": 140922763,
                "url": "https://finnhub.io/api/news?id=dc4955263ecd30f9602dfc000f5bacd34f86464174631084d5e636d601f094f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "DHR heads into Q2 earnings with bioprocessing and diagnostics strength, but rising costs and debt could pressure profitability.",
                "category": "company",
                "datetime": 1784216760,
                "headline": "Danaher Gears Up to Post Q2 Earnings: Is a Beat in the Offing?"
              },
              {
                "id": 140921098,
                "url": "https://finnhub.io/api/news?id=3ee3e86383b3ce5a581b714972278ee2441b8d4bec1066462ce8d89a05a83334",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Insurance giant UnitedHealth Group (UNH) is out with its second quarter earnings on Thursday, raising its full-year outlook alongside its reported $112 billion in quarterly revenue. The stock has jumped in Thursday trading. Mizuho Americas healthcare equity strategist Jared Holz takes a closer look at the insurer's stock performance and the role Medicare Advantage had in its figures.",
                "category": "company",
                "datetime": 1784213644,
                "headline": "UnitedHealth stock jumps on Q2 earnings, raises full-year outlook"
              },
              {
                "id": 140923118,
                "url": "https://finnhub.io/api/news?id=849660181dbdce21c5283300d80d1ffbd4882504fe8ef32a9722935ced89a103",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/16/Konskie--Poland---September-07--2025-Uni.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "UnitedHealth's (UNH) strong earnings and raised outlook lifted healthcare ETFs despite a sharp decline in Medicare Advantage membership.",
                "category": "company",
                "datetime": 1784208257,
                "headline": "UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses"
              },
              {
                "id": 140919761,
                "url": "https://finnhub.io/api/news?id=9e2d7a9c3858d95b05e36040d4d9fa67670edc9e6fdf517dd74ddb28b77b88f9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Elevance Health raised its profit forecast and the stock promptly fell. Here’s the one number that explains why investors headed for the exits.",
                "category": "company",
                "datetime": 1784207995,
                "headline": "The Medicaid Problem That Swallowed an Earnings Beat"
              },
              {
                "id": 140919763,
                "url": "https://finnhub.io/api/news?id=663388885645ae2288412ad111d85e992c0335a6ceb3a7bf1f9c0864216c5dd2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The core narrative surrounding UnitedHealth Group (UNH) is dominated by its successful margin recovery, yet the underlying data reveal a shift from a growth compounder to a vulnerable margin defender. The defining insight is not the massive bottom-line beat of a $6.38 adjusted earnings per share against a $4.94 consensus estimate. Rather, it is the deliberate contraction of the core membership base to support margins in the face of significant regulatory headwinds.",
                "category": "company",
                "datetime": 1784206721,
                "headline": "Is UNH Stock Sacrificing Its Core Growth Engine To Save Margins?"
              },
              {
                "id": 140919291,
                "url": "https://finnhub.io/api/news?id=195f8e2045a457bd41c82088ca85aafdc16620b26b540f6e0008b4d2a9b08064",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "CVS",
                "summary": "The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.",
                "category": "company",
                "datetime": 1784205300,
                "headline": "What's going on in today's pre-market session: S&P500 movers"
              },
              {
                "id": 140919768,
                "url": "https://finnhub.io/api/news?id=f42558d6ad029166956228b7d675af30dc5b6485d970b7e2c2615347057d3dd9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The stock is priced for strength, but a deep and persistent drag from one of its largest divisions could challenge the optimistic narrative.",
                "category": "company",
                "datetime": 1784205032,
                "headline": "The Medicaid Problem Weighing On Elevance Health Stock"
              },
              {
                "id": 140919728,
                "url": "https://finnhub.io/api/news?id=ea562688189364310e928b87698b0b1ae06ad5b160972c5e0599966669084dc2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The stock's current valuation looks steep, but for a patient holder, the price tag on future earnings tells a very different story.",
                "category": "company",
                "datetime": 1784205031,
                "headline": "The Real Price of Admission for CVS Health Stock"
              },
              {
                "id": 140919904,
                "url": "https://finnhub.io/api/news?id=04eecd169a0bd8cba60302840ab7e7a45d3334d0faad0de4285a1b68d126a94d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Aetna president Steve Nelson chats with Yahoo Finance's Julie Hyman about the impact of GLP-1 weight-loss drugs on health insurers.",
                "category": "company",
                "datetime": 1784203200,
                "headline": "The 'important' thing to remember when it comes to GLP-1s & healthcare: Aetna president"
              },
              {
                "id": 140918841,
                "url": "https://finnhub.io/api/news?id=7fc32469cbc32693e09225dbb6db0e9326b415c41557fdcf85b7c7c9d24b74f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs and gave a big boost to its full-year outlook.  Humana, Centene and CVS Health all got a sizable lift from the warm reception for UnitedHealth's earnings report.",
                "category": "company",
                "datetime": 1784199650,
                "headline": "UNH Stock Flashes Buy Signal On Massive Earnings Beat"
              },
              {
                "id": 140912829,
                "url": "https://finnhub.io/api/news?id=24098b6ae142cdcbcbda419654be673d95009468fd3f2c82daa675ab7efa5ccf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Elevance Health beats Q2 EPS and revenue estimates, raises 2026 adjusted EPS outlook despite lower earnings, softer membership and higher expenses.",
                "category": "company",
                "datetime": 1784134860,
                "headline": "ELV Beats Q2 Earnings Estimates on Higher CarelonRx Product Revenues"
              },
              {
                "id": 140909794,
                "url": "https://finnhub.io/api/news?id=9a8ecd0bae3cc3e80101703c098819c824071ccc0af2cfbbb742fa48ef06a42f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?",
                "category": "company",
                "datetime": 1784122203,
                "headline": "Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?"
              },
              {
                "id": 140909795,
                "url": "https://finnhub.io/api/news?id=1b47d596112422920f3e6d85275e61af22568009f53e93748458b83d713e1535",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
                "category": "company",
                "datetime": 1784121301,
                "headline": "CVS Health Corporation (CVS) Soars to 52-Week High, Time to Cash Out?"
              },
              {
                "id": 140908434,
                "url": "https://finnhub.io/api/news?id=3d73f2dc7adaa54a1b30b53dff571a7e5e72ab3df7bea5908bbcccac61f52df7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Aetna®, a CVS Health® company (NYSE: CVS) today announced findings from the second Aetna Provider Survey. The Aetna Provider Survey is a quarterly study that polls the U.S. provider market to better understand their perceptions on payers and the industry, today and into the future. This survey series is intended to solicit timely, objective feedback from the U.S. provider market so we can identify opportunities to change the provider-payer dynamic and deepen trust over time.",
                "category": "company",
                "datetime": 1784118600,
                "headline": "Aetna provider survey reveals increased payer trust and tangible benefits of digital tools to improve patient outcomes"
              },
              {
                "id": 140907461,
                "url": "https://finnhub.io/api/news?id=d9e07d894e9e87b569ae71b67f25b242f8405d36966fddfe8c414ae2975ec6b2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Investing.com -- Elevance Health’s Health Benefits operating profit collapsed in the second quarter of 2026, igniting a broad premarket selloff across the managed-care sector even as the insurer’s headline earnings handily beat estimates and full-year guidance was lifted.",
                "category": "company",
                "datetime": 1784114481,
                "headline": "Insurance stocks fall after Elevance Health results show margin pressure"
              },
              {
                "id": 140906737,
                "url": "https://finnhub.io/api/news?id=6ba9136396b7e4d0bd55b83239174975d7377e19fa185d76fee192bfde4ecb2c",
                "image": "https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp",
                "source": "ChartMill",
                "related": "CVS",
                "summary": "CVS Health Corp (CVS) earns a perfect 10 technical rating and a 9 setup rating, signaling a high-conviction breakout candidate consolidating near its 52-week high.",
                "category": "company",
                "datetime": 1784109029,
                "headline": "CVS Health Corp (NYSE:CVS) Flashes a Perfect Technical Breakout Setup With High-Grade Consolidation"
              },
              {
                "id": 140908785,
                "url": "https://finnhub.io/api/news?id=b402367c33420346ec19fc392d5631e66699d8281c555a33266d318fc75b3065",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/15/CVS-Pharmacy.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "FTC settlement with CVS Caremark targets rebate practices, pharmacy access and transparency, with potential consumer savings of up to $13 billion.",
                "category": "company",
                "datetime": 1784104184,
                "headline": "FTC Says CVS Caremark Settlement Could Save Consumers Upto $13 Billion"
              },
              {
                "id": 140903049,
                "url": "https://finnhub.io/api/news?id=adc52c3dc60de0293f8c9856454bc897b7ed52ec60e2c0c0f523c00b94c7ec5b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The Federal Trade Commission announced a settlement with  CVS Health’s  pharmacy benefit manager business on Tuesday, the agency’s second major agreement this year with drug industry middlemen.  Pharmacy-benefit managers, or PBMs, play a key role in negotiating with drug companies and selecting which prescription drugs will be covered by an insurance plan.  In litigation filed in 2024 during the Biden administration, the commission alleged that rebates and fees collected by major PBMs from drug manufacturers artificially inflated the price of insulin.",
                "category": "company",
                "datetime": 1784062020,
                "headline": "FTC Reaches Settlement With CVS Health Over Insulin Prices"
              },
              {
                "id": 140903050,
                "url": "https://finnhub.io/api/news?id=c65ff57bb0a8074d5c1b073283a0486db49d5960f9df5c25cacb8c08ba16f198",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "We recently published Jim Cramer Discussed These 22 Stocks Including A Hidden Oil & Energy Play. CVS Health Corporation (NYSE:CVS) is one of the stocks discussed by Jim Cramer. Healthcare insurance provider and pharmacy firm CVS Health Corporation (NYSE:CVS) is another favorite Jim Cramer stock. The shares are up by 61% over the past year and […]",
                "category": "company",
                "datetime": 1784061543,
                "headline": "Jim Cramer Reveals Why CVS Health Corporation (CVS) Is in a Strong Position"
              },
              {
                "id": 140901496,
                "url": "https://finnhub.io/api/news?id=36bdbd2540c7ac28b1511781b79e57a7ad64a84fa80dc468e014bf4239823363",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "(Updates with Claritev's response in the fourth paragraph.) The US Justice Department recently se",
                "category": "company",
                "datetime": 1784056416,
                "headline": "Update: Market Chatter: DOJ Expands Antitrust Probe Into Claritev"
              },
              {
                "id": 140901620,
                "url": "https://finnhub.io/api/news?id=b07756df64da61bd05bc4bdbe454ed7fc9754a518e14244d0f87a6f7dcc24410",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Caremark today announced a global settlement with the Federal Trade Commission (FTC) which further advances the company's leadership in delivering greater affordability for prescription drugs. The settlement resolves all outstanding FTC litigation and investigations related to CVS Health® (NYSE: CVS) — including its pharmacy benefits management and affiliated pharmacy businesses — involving rebate, pharmacy network contracting, and vertical integration issues.",
                "category": "company",
                "datetime": 1784055900,
                "headline": "CVS Caremark Announces Agreement with FTC To Further Advance Industry-Leading Approaches to Transparency and Affordability"
              },
              {
                "id": 140899918,
                "url": "https://finnhub.io/api/news?id=d889531f936a01f23a6d375e7df8d4104743c0111a617915aad6c1f905eae111",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Dividend affirmation and GLP-1 expansion set the tone CVS Health (CVS) recently affirmed a quarterly dividend of $0.665 per share and expanded its GLP-1 support programs across pharmacies, MinuteClinic, and virtual channels, giving investors fresh information on both income and operations. See our latest analysis for CVS Health. Recent news around the dividend and GLP-1 expansion has arrived alongside strong share price momentum, with CVS Health’s 90-day share price return of 36.43% and...",
                "category": "company",
                "datetime": 1784045578,
                "headline": "CVS Health (CVS) Expands GLP 1 Support, Does The Stock Look Fully Valued?"
              },
              {
                "id": 140903051,
                "url": "https://finnhub.io/api/news?id=52506db3a6c4b75f0e252a6fa93a2fc4b349f4a46b28000439108c0810df6bc2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Terms of the deal announced Tuesday are very similar to those the FTC reached with Express Scripts earlier this year, including requiring the PBM to stop preferring higher cost versions of drugs on standard formularies.",
                "category": "company",
                "datetime": 1784041849,
                "headline": "CVS Caremark reaches settlement with FTC over insulin suit"
              },
              {
                "id": 140903934,
                "url": "https://finnhub.io/api/news?id=9c23b7e3c2bed1d6ae54db4554f3455523d7152c31c74ccc6e4d0ee7e183b285",
                "image": "",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "CVS Caremark today announced a global settlement with the Federal Trade Commission (FTC) which further advances the company's leadership in delivering greater affordability for prescription drugs. The settlement",
                "category": "company",
                "datetime": 1784041695,
                "headline": "CVS Health's CVS Caremark Announces Settlement With U.S. Federal Trade Commission To Resolve All Outstanding Litigation, Probe"
              },
              {
                "id": 140903935,
                "url": "https://finnhub.io/api/news?id=c7e5b7065ef4a87b9b6b5635acf89e3319174bcb52510f6af130f25b625d3b41",
                "image": "",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "Truist Securities  analyst David Macdonald   maintains CVS Health (NYSE:CVS) with a Buy and raises the price target from $108 to $118.",
                "category": "company",
                "datetime": 1784021194,
                "headline": "Truist Securities Maintains Buy on CVS Health, Raises Price Target to $118"
              },
              {
                "id": 140890002,
                "url": "https://finnhub.io/api/news?id=d8c2e200c9611f9b0e535a383ec14dcf3c85fa8c298a7875df83cf79809fe853",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The health care giant commands a premium price over its rivals, but its core numbers tell a different story. Is the market seeing a future that isn't in the results yet.",
                "category": "company",
                "datetime": 1783965262,
                "headline": "The Premium On CVS Stock Vs What Its Peers Deliver"
              },
              {
                "id": 140888416,
                "url": "https://finnhub.io/api/news?id=fd4d4d323ca3fedefea2cc6d440ffd8cf63824e0800c451fe6d924a57bcada11",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Humana targets a 3% Medicare Advantage margin by 2028 while pursuing 25% 2026 membership growth and rebuilding profitability despite industry headwinds.",
                "category": "company",
                "datetime": 1783960620,
                "headline": "Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?"
              },
              {
                "id": 140886737,
                "url": "https://finnhub.io/api/news?id=ed5adf651f473be28d7fff45440ecb8e44467ae4fb062f0f9154d6b5ca4e8ffe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health Corporation (NYSE:CVS) was among Jim Cramer’s stock calls on Mad Money, as he advised investors to stick with the largest tech companies in the market. Noting that healthcare stocks have been out of favor for some time, a caller asked if the stock is a buy, sell, or hold. Cramer stated: It’s a […]",
                "category": "company",
                "datetime": 1783956359,
                "headline": "Jim Cramer Says “Buy the Stock of CVS, I Sure Wish I’d Done It for My Trust”"
              },
              {
                "id": 140885702,
                "url": "https://finnhub.io/api/news?id=d4afa9dd7339c3de219f5cd1672279bad693f49b052bccac60f22fd0e9abad41",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The creator of the Evolution of Distribution® who built Amazon's sports nutrition category from ground zero and placed brands with America's largest retailers, including Walmart, Costco, CVS, and Walgreens. BOCA RATON, FL / ACCESS Newswire / July ...",
                "category": "company",
                "datetime": 1783947600,
                "headline": "From Brooklyn to the Biggest Names in Sports and Entertainment: Mitch Gould's Quintessential American Success Story"
              },
              {
                "id": 140887883,
                "url": "https://finnhub.io/api/news?id=0fb4879d52e672c0242f287dd4a6e648ca3aaabc3243be8661d2beb3c07c842c",
                "image": "",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "Wells Fargo  analyst Stephen Baxter   maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $103 to $123.",
                "category": "company",
                "datetime": 1783937236,
                "headline": "Wells Fargo Maintains Overweight on CVS Health, Raises Price Target to $123"
              },
              {
                "id": 140884411,
                "url": "https://finnhub.io/api/news?id=b4219694bcd52c04d319364a773c63e6a86eec98d629f5b513ea0832778792d3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "After a rocky start to the year, health insurer stocks have roared back.  The insurers are trying to end a difficult cycle that began about three years ago, when healthcare use, and the costs to cover it, accelerated postpandemic.  The fund’s top 10 holdings encompass six health insurers, three of which—  UnitedHealth Group  Aetna parent  CVS Health  and  Elevance Health  —comprise more than 40% of the fund.",
                "category": "company",
                "datetime": 1783926000,
                "headline": "Elevance and UnitedHealth Earnings Are Next Test for Hot Health Insurer Stocks"
              },
              {
                "id": 140887884,
                "url": "https://finnhub.io/api/news?id=d6b97e5e2d0a0da4424ed28339ad0a3425ddba2d38f6891101f093022cabcc9c",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/13/Closeup-one-hundred-US-dollar-bills-unde.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "HHS watchdog projected $5.56 billion in recoveries and savings over six months despite enforcement falling to a two-year low.",
                "category": "company",
                "datetime": 1783912149,
                "headline": "Federal Health Watchdog Projects $5.56 Billion in Recoveries and Savings, Despite Enforcement Hitting Two-Year Low"
              },
              {
                "id": 140864127,
                "url": "https://finnhub.io/api/news?id=9227f326155bc65e6ac391b8296334e42172064228b4e320a60cf8fcc20478ce",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "You don't need to predict a recession to prepare your portfolio. These two stocks can help.",
                "category": "company",
                "datetime": 1783700400,
                "headline": "2 Recession-Resistant Dividend Stocks to Buy and Hold"
              },
              {
                "id": 140864374,
                "url": "https://finnhub.io/api/news?id=0cfdc792df712b63b4559ade52d841760c3f609436c75a9986220637a2a5d29f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "BKD's Q2 weighted average occupancy rises to 82.4% as steady resident demand and RevPAR growth expectations set the stage for its upcoming earnings.",
                "category": "company",
                "datetime": 1783697160,
                "headline": "Brookdale Senior Q2'26 Sneak Peek: Occupancy Volume Rises to 82.4%"
              },
              {
                "id": 140866270,
                "url": "https://finnhub.io/api/news?id=a67e98e1936b6a3599b8cb3554e4ac78afa1ae0c78433ca992aa6f6b531a158e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health is scheduled to post its second-quarter results in August, and analysts project a single-digit earnings rise.",
                "category": "company",
                "datetime": 1783696388,
                "headline": "What to Expect From CVS Health's Q2 2026 Earnings Report"
              },
              {
                "id": 140861701,
                "url": "https://finnhub.io/api/news?id=665dba92bf5830430e5f158fd9ac6e8ce22d2983a146d937da920ce5d89e419d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on August 3, 2026, to holders of record on July 23, 2026.",
                "category": "company",
                "datetime": 1783691220,
                "headline": "CVS Health declares quarterly dividend"
              },
              {
                "id": 140872557,
                "url": "https://finnhub.io/api/news?id=b9be7aace0fb1298084ee6f1c29f7010abf542cfa730f26e41e743f122829c36",
                "image": "",
                "source": "Benzinga",
                "related": "CVS",
                "summary": "https://www.wsj.com/business/deals/warburg-pincus-near-over-7-billion-deal-for-specialty-pharmacy-company-99030b6f",
                "category": "company",
                "datetime": 1783687982,
                "headline": "'Warburg Pincus Near Over $7 Billion Deal For Specialty-Pharmacy Company; PANTHERx Rare Has Been Owned By A Group Of Private-Equity Firms Since 2022' - WSJ Exclusive"
              },
              {
                "id": 140861604,
                "url": "https://finnhub.io/api/news?id=61a62b28568787b7d6c7c35482b3faf80155aede3728d9b5b2daab140f8f391b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The health care giant sent a torrent of cash to its owners, but the stock itself told a very different story about the last five years.",
                "category": "company",
                "datetime": 1783684540,
                "headline": "UNH Showered Owners With Cash. The Stock Did Not Cooperate"
              },
              {
                "id": 140861992,
                "url": "https://finnhub.io/api/news?id=94d62c107bcd14be6eb253b259332c2fafac7e6bb29a5f0ff28a1e96905c5b56",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Plus, two hotel management companies merged, and a real estate investment firm nabbed an eight-property portfolio.",
                "category": "company",
                "datetime": 1783675933,
                "headline": "Lodging Lowdown: Choice Hotels taps AI leader to board, Aspen Hospitality launches luxury Nell Hotels brand"
              },
              {
                "id": 140863051,
                "url": "https://finnhub.io/api/news?id=baad49636f7dbc8c8e64c090181780661199c5c96ddbe7f028f05f86fc4eb034",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "The settlement could be the end of a long legal saga for Omnicare, which filed for bankruptcy last year after a judge ordered the company to pay nearly $950 million for fraudulently billing government health programs.",
                "category": "company",
                "datetime": 1783673400,
                "headline": "Bankrupt Omnicare reaches $440M deal with DOJ in fraud case"
              },
              {
                "id": 140859173,
                "url": "https://finnhub.io/api/news?id=42b16f3746247de4dda3225c0ac6a13b55da1683c8b56176052d506380a2d360",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CVS",
                "summary": "Choice Hotels International (NYSE:CHH) has appointed Ali Keshavarz, CVS Health's President and Chief Data & Analytics Officer, to its Board. The company is also undergoing changes across several indices, including removals from certain value and small or mid cap benchmarks. At the same time, Choice Hotels has been added to the Russell 1000 Dynamic Index. Choice Hotels International enters this news cycle with its stock trading at $109.61 and a mixed return profile. The shares are up 14.1%...",
                "category": "company",
                "datetime": 1783663953,
                "headline": "Choice Hotels (CHH) Appoints CVS Data Chief To Board As Index Changes Hit"
              },
              {
                "id": 140860042,
                "url": "https://finnhub.io/api/news?id=d510052766cce023a43d6ec9400dd55e4c3f09b161a8fe025ee0193c2bbd9867",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2230977259/image_2230977259.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CVS",
                "summary": "Healthcare space has been a perennial target for US antitrust enforcers, but Trump's second administration has been much more willing than its predecessor to settle with insurers.",
                "category": "company",
                "datetime": 1783663200,
                "headline": "Pharmacy Benefit Manager Suit Shows Trump Admin's Keenness For Deals"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 1,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 193,
            "discarded_article_count": 94
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 11.9,
        "grade": "較差",
        "items": {
          "bbPoints": 1.8,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 0.6,
          "macdPoints": 0.8,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.6,
            "vcp_reason": "跌縮量(近10日4日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 2,
              "vol_ref": 7851856.666666667,
              "down_days": 7,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 8415070,
              "avg_vol_20": 8479300,
              "avg_vol_30": 7851856.666666667,
              "range_pct_10": 0.17241379310344826,
              "range_pct_20": 0.17951933124346925,
              "range_pct_30": 0.17951933124346925,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.0717299560146496,
              "dist_to_20d_high": 0.1353451391398627,
              "down_shrink_days": 4,
              "breakout_level_20d": 110.68,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.9604190919674035
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 0.8,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.5,
            "details": {
              "atrPct": 3.310240334378265,
              "turnoverUsdM": 1186.61301,
              "liquidityPoints": 0.8,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.CVS",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 89.3642,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 2.5,
              "macd_score": 1,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 6.6,
            "take_profit_price": 102.1203,
            "target_multiplier": 1.9,
            "technical_strength": 1.6,
            "take_profit_percent": 6.7
          },
          "positionPoints": 1.5,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 6.62048066875653,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [
    {
      "code": "VIX_MISSING",
      "symbol": "US.CVS",
      "message": "VIX market context is required for market environment scoring",
      "missing": [
        "VIX"
      ],
      "provider": "scoring"
    }
  ],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": false,
    "missingFields": [
      "VIX"
    ],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 100,
    "atr": {
      "atr": 3.1679,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.31
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -239.7
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.0571
    },
    "kdj": {
      "d": 28.45,
      "j": 7.76,
      "k": 21.56,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 37.48
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": -20147500,
      "recentSlope": -5920410,
      "previousSlope": 2172850
    },
    "rsi": 27.1,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 107.5866,
      "position": "SAR喺價上",
      "distancePct": 12.42,
      "previousTrend": "下降"
    },
    "ma50": 101.87,
    "macd": {
      "macd": -1.0638955821587928,
      "trend": "看跌",
      "signal": 0.509000380276581,
      "histogram": -1.5728959624353738
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 104.4588,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.44,
      "score": 6,
      "avgVolume": 8631450,
      "currentVolume": 12399300
    },
    "derived": {
      "ma20": 105.2845,
      "ma50": 101.87,
      "prevClose": 96.22,
      "avgVolume10": 9117950,
      "avgVolume20": 8631450,
      "changePercent": -0.54,
      "avgVolumeForScore": 8631450
    },
    "ma_cross": {
      "ma20": 105.2845,
      "ma50": 101.87,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 105.707,
      "prevMa50": 101.7974,
      "spreadPct": 3.35,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 97.6495,
      "upper": 112.9195,
      "position": "下半部"
    },
    "rsi_short": 8.25,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.44
    }
  }
}

{
  "close": 95.7,
  "volume": 12399300,
  "changePercent": -0.54
}